Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3034780	fs-ace	U/l (u/l)	16047	32230	0.05%
3034780	fs-ace	— (—)	2046	3287	100.00%	Distribution not available
3034780	s-ace	U/l (u/l)	1402	2203	0.18%
3034780	s-ace	— (—)	673	769	100.00%	Distribution not available
3034780	fs-ace	U/l_______ (u/l)	316	618	0.00%
3034780	fs-ace	U/L (u/l)	289	541	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Heart failure, strict

2499

7461

2.44

321.67

2.0

1.9

36.46

39.57

u/l

8.15

1975

6600

Disorders of mineral metabolism

659

1333

5.76

317.12

3.0

1.9

41.04

39.81

u/l

0.61

582

1193

GASTRO-related operations

2947

6617

2.30

311.76

2.0

40.02

39.74

u/l

0.29

2698

5985

Any gastric operation

2947

6617

2.30

311.76

2.0

40.02

39.74

u/l

0.29

2698

5985

Asthma, hospital admission 2, infections

2603

11610

2.28

309.41

2.1

2.0

38.45

39.86

u/l

2.92

2325

10366

Asthma-related infections

2603

11610

2.28

309.41

2.1

2.0

38.45

39.86

u/l

2.92

2325

10366

Medical observation and evaluation for suspected diseases and conditions

2626

5442

2.56

307.65

2.1

1.9

40.05

39.59

u/l

0.46

2354

4869

Disorders of calcium metabolism

570

955

7.22

307.65

3.1

2.0

40.80

39.94

u/l

0.34

502

851

Anterior Iridocyclitis

1511

3616

4.77

307.65

2.4

2.0

39.50

39.69

u/l

0.13

1407

3231

Iridocyclitis

1739

4067

4.88

307.65

2.4

2.0

39.68

39.47

u/l

0.15

1611

3603

Other heart diseases, wide

4210

11180

2.38

307.65

2.5

1.9

39.04

40.52

u/l

4.07

3690

10356

Other specific joint derangements/joint disorders

3300

8893

2.41

307.65

2.2

2.1

39.85

39.99

u/l

0.14

2988

8042

Polyarthropathies

3304

8095

2.76

307.65

1.9

2.1

38.35

39.97

u/l

3.99

2968

7274

All kidney diseases

4238

14035

2.10

307.65

2.3

2.0

39.03

39.92

u/l

1.82

3761

12677

Malaise and fatigue

2142

6771

2.59

307.65

1.9

1.8

38.75

39.33

u/l

0.60

1880

5975

Fever of other and unknown origin

2984

8215

3.34

307.65

2.0

1.9

39.07

39.56

u/l

0.56

2720

7311

Renal failure

2423

7156

3.08

307.65

2.4

1.8

39.50

39.10

u/l

0.36

2108

6220

Heart failure,strict

2371

6449

2.71

307.65

2.1

1.8

36.38

39.70

u/l

8.72

1875

5745

Other soft tissue disorders, not elsewhere classified

3855

10909

2.08

307.65

2.0

39.66

39.65

u/l

0.01

3467

9828

ILD, hospital admissions

1051

2388

5.03

307.65

1.9

38.87

38.63

u/l

0.12

967

2058

COPD differential diagnosis

3159

5687

2.90

307.65

2.4

1.2

39.89

39.00

u/l

1.37

2869

5037

Acute and subacute iridocyclitis

1406

3350

4.78

307.65

2.3

2.0

39.60

39.55

u/l

0.03

1312

2991

ILD differential diagnosis

3158

5684

2.90

307.65

2.4

1.2

39.89

39.01

u/l

1.34

2868

5034

Enlarged lymph nodes

1552

2265

8.23

307.65

3.6

1.8

43.16

39.27

u/l

7.42

1457

2011

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

653

1129

6.93

307.65

1.8

37.30

38.68

u/l

0.75

576

984

Abnormalities of breathing

4136

9389

2.63

307.65

2.2

1.9

39.66

39.88

u/l

0.25

3709

8527

Renal tubulo-interstitial diseases

3746

13390

2.13

307.65

2.3

1.9

39.41

39.69

u/l

0.32

3301

12032

Other and unspecified polyneuropathies, also in other diseases

1278

3185

4.52

307.65

1.8

1.9

40.23

38.68

u/l

1.59

1120

2780

Asthma (only as main-diagnosis)

3233

5631

3.37

307.65

2.2

1.2

38.91

39.02

u/l

0.10

2943

4987

Other heart diseases

2427

5096

3.29

307.65

2.8

2.0

38.87

41.46

u/l

6.37

2113

4851

Asthma (mode)

3460

5684

3.36

307.65

2.2

1.2

39.21

39.01

u/l

0.19

3151

5034

General symptoms and signs

4845

9744

2.60

307.65

2.2

1.9

39.84

39.71

u/l

0.14

4395

8737

Interstitial lung disease endpoints

1058

2411

5.00

307.65

1.9

38.85

38.64

u/l

0.10

974

2071

Symptoms and signs involving the circulatory and respiratory systems

4075

9410

2.24

307.65

2.1

1.9

39.63

39.88

u/l

0.28

3697

8548

Dyspnoea

4288

13517

2.39

307.65

2.1

2.0

39.18

39.79

u/l

1.03

3782

12139

Finngen Rheumatological endpoints

4017

10906

2.16

307.65

1.9

2.1

38.66

40.44

u/l

6.00

3652

9854

Disorders of sclera, cornea, iris and ciliary body

2907

11227

2.75

307.65

2.2

2.0

39.65

39.69

u/l

0.03

2675

10031

Polyneuropathies and other disorders of the peripheral nervous system

1376

3707

4.13

307.65

1.8

1.9

40.12

38.87

u/l

1.22

1207

3240

Cardiac arrhythmias

2624

7177

2.44

307.65

2.6

2.0

39.52

40.97

u/l

2.74

2325

6782

Asthma, unspecified (mode)

2534

5343

3.61

307.65

2.2

1.2

38.89

38.83

u/l

0.04

2280

4713

Chronic kidney disease

1759

4915

3.73

307.65

2.5

1.7

39.85

38.71

u/l

1.25

1532

4226

Headache

2839

9047

2.52

307.65

2.1

1.9

39.53

39.73

u/l

0.20

2585

8125

Myocarditis

507

600

10.64

307.65

7.9

1.8

37.81

42.09

u/l

3.56

469

564

Interstitial lung disease

1058

2411

5.00

307.65

1.9

38.85

38.64

u/l

0.10

974

2071

Sarcoidosis

3206

2018

33.97

307.65

6.0

1.2

45.77

38.76

u/l

31.31

3057

1770

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

1303

1777

3.81

307.65

2.1

1.8

40.06

39.11

u/l

0.74

1193

1623

Excluding asthma or asthma-COPD overlap

3166

5692

2.90

307.65

2.4

1.2

39.93

39.05

u/l

1.37

2874

5044

Asthma

3501

5631

3.37

307.65

2.2

1.2

39.23

39.02

u/l

0.20

3189

4987

Autoimmune diseases

4657

11048

2.21

307.65

2.0

2.1

39.43

39.73

u/l

0.39

4247

9865

Pain in throat and chest

3380

9257

2.23

307.65

2.2

2.0

39.14

39.94

u/l

1.30

3035

8397

ILD medications

6310

10552

3.42

307.65

2.7

1.5

38.64

40.53

u/l

8.42

5791

9382

Diagnoses used for exclusion with ILD

3554

4026

11.84

307.65

5.6

1.2

45.04

38.15

u/l

42.55

3366

3469

Asthma (diagnoses ohter than nonallergic)

3813

15174

2.10

307.65

2.2

2.0

39.07

39.79

u/l

1.34

3455

13582

Autoimmune diseases related-to ILD

3912

14619

2.33

307.65

1.8

2.1

38.48

40.18

u/l

5.72

3545

13071

Autoimmune diseases excluding thyroid diseases

5018

11002

2.58

307.65

1.9

2.1

39.13

39.72

u/l

1.05

4553

9825

Other systemic involvement of connective tissue

1519

4941

3.33

307.65

1.8

2.0

38.53

39.35

u/l

0.80

1377

4361

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

885

638

11.33

307.65

2.0

2.3

39.02

42.00

u/l

2.28

820

577

ILD medications: prednisolone, methylprednisolone, prednisone

6173

10428

3.50

307.65

2.9

1.5

38.88

40.55

u/l

6.52

5650

9264

Heart failure, not strict

3402

9669

2.48

307.65

2.3

1.9

37.60

40.34

u/l

9.24

2823

8730

Heart failure and antihypertensive medication

1371

2353

4.11

307.65

2.3

1.9

35.81

43.04

u/l

20.14

1077

2223

Inflammatory bowel disease treatment related agents

6327

11699

3.18

307.65

2.8

1.5

38.81

40.37

u/l

6.06

5782

10439

Other interstitial pulmonary diseases

1058

2400

5.02

307.65

1.9

38.85

38.62

u/l

0.12

974

2064

All chronic kidney diseases

2691

8137

2.79

307.65

2.4

1.9

39.23

39.62

u/l

0.38

2356

7202

ILD medications: immunosuppressive drugs

3819

9670

3.86

307.65

2.6

1.5

37.93

40.69

u/l

12.21

3522

8605

Other systemic involvement of connective tissue (FG)

1493

4079

3.91

307.65

1.8

2.0

38.29

39.91

u/l

2.14

1354

3603

Other respiratory diseases principally affecting the interstitium

1168

2820

4.65

307.65

1.8

38.65

38.80

u/l

0.08

1069

2428

Autoimmune diseases excluding thyroid diseases, strict definition

4821

10633

2.58

307.65

1.9

2.1

39.14

39.78

u/l

1.15

4374

9494

Asthma (only as main-diagnosis), excluding more controls

3171

5106

3.61

307.65

2.2

1.2

38.90

39.44

u/l

0.65

2890

4619

Systemic connective tissue disorders

2091

6464

3.53

307.65

1.7

2.0

37.82

39.70

u/l

3.85

1901

5702

Asthma, unspecified (mode), excluding more controls

2491

4843

3.90

307.65

2.3

1.2

38.90

39.27

u/l

0.35

2250

4365

Cardiomyopathy

1025

2548

4.44

307.65

2.6

1.7

34.23

39.46

u/l

9.37

757

2294

ILD, hospital admissions 1, main diag only

977

2149

5.24

307.65

1.8

38.88

38.53

u/l

0.18

897

1854

First line medication for Crohn's disease

5791

10504

3.13

307.65

2.7

1.5

38.78

40.39

u/l

5.98

5304

9368

Asthma, excluding more controls

3406

5106

3.60

307.65

2.2

1.2

39.25

39.44

u/l

0.17

3107

4619

Certain disorders involving the immune mechanism

3546

3031

18.90

307.65

5.6

1.2

45.02

38.80

u/l

32.31

3368

2676

Other specified/unspecified arthritis

1460

4643

3.38

307.65

1.9

2.0

37.70

39.73

u/l

3.41

1327

4136

Reimbursement for rheumatic diseases

2658

11522

2.41

307.65

1.7

2.1

37.92

40.10

u/l

6.77

2428

10282

Other pulmonary diagnosis

2942

5692

2.68

307.65

2.0

1.2

39.15

39.05

u/l

0.09

2667

5044

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

4564

10613

4.11

307.65

2.8

1.8

40.76

39.20

u/l

4.54

4166

9287

Cough

2008

6437

3.08

307.65

2.3

1.9

40.79

39.74

u/l

1.42

1831

5762

Pain in joint

2743

6551

2.69

307.65

2.2

2.1

39.80

39.98

u/l

0.16

2473

5834

Other arthritis (FG)

1677

5389

3.35

307.65

1.9

2.1

37.79

40.29

u/l

5.52

1522

4805

Second line medication for Crohn's disease

3141

11738

2.85

307.65

2.8

1.9

37.73

40.21

u/l

9.33

2900

10493

Abnormal findings on diagnostic imaging of lung

3547

7777

4.84

307.65

3.0

1.7

40.94

38.95

u/l

5.37

3243

6716

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

6593

11849

4.07

307.65

3.6

1.2

42.32

38.31

u/l

33.23

6006

10552

L04AX Other immunosuppressants

3068

11386

2.88

307.65

2.8

1.9

37.66

40.19

u/l

9.44

2833

10164

Used for control exclusion in common control thyroid runs

4285

10076

2.22

307.65

2.0

2.1

39.26

39.81

u/l

0.87

3920

8989

Oral corticosteroids

6227

11448

3.40

307.65

2.9

1.5

38.75

40.36

u/l

6.34

5677

10201

Anaemias

1076

1649

4.45

307.65

2.0

40.11

40.87

u/l

0.46

976

1591

Chronic iridocyclitis

476

740

8.07

305.81

3.0

2.0

38.40

39.59

u/l

0.54

446

658

All-cause Heart Failure

2427

7329

2.41

305.05

2.0

1.9

36.44

39.59

u/l

8.20

1918

6483

Cardiovascular diseases (excluding rheumatic etc)

2564

6372

2.39

303.02

2.4

1.9

39.22

41.09

u/l

4.00

2313

6088

ILD, hospital admission 2, with pulmonary infections

649

1339

5.49

302.95

1.9

1.8

37.96

39.38

u/l

0.83

598

1145

Abnormal findings on examination of blood, without diagnosis

2146

8249

2.48

301.43

1.9

40.44

38.84

u/l

2.49

1901

7255

Bacterial infection, other or unspecified, including avohilmo

2533

9399

2.30

298.68

1.8

2.0

37.91

39.87

u/l

4.32

2197

8308

Symptoms and signs involving the skin and subcutaneous tissue

3135

14719

2.09

298.05

2.1

2.0

39.89

39.64

u/l

0.28

2843

13152

3573

10610

2.03

287.70

2.1

2.0

38.93

40.28

u/l

3.15

3203

9545

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

3573

10610

2.03

287.70

2.1

2.0

38.93

40.28

u/l

3.15

3203

9545

Asthma, hospital admissions , main diagnosis only

3417

15335

2.00

287.20

2.1

2.0

38.92

39.85

u/l

1.92

3100

13745

Bacterial infection, other or unspecified

2319

8709

2.35

286.89

1.9

37.81

39.82

u/l

4.18

2007

7684

Implicit Sepsis, including avohilmo

3400

12356

2.03

286.37

2.1

2.0

39.09

39.89

u/l

1.26

2985

11077

Chronic lower respiratory diseases

4751

13930

1.85

282.87

2.1

2.0

39.32

39.97

u/l

1.23

4308

12503

Implicit Sepsis

3145

11546

2.08

282.69

2.1

2.0

38.92

39.85

u/l

1.52

2762

10297

Cardiovascular diseases

2356

5373

2.41

278.59

2.1

1.9

39.31

40.93

u/l

3.06

2151

5153

Infections, IBD-co-morbidities

699

1026

5.10

277.95

1.8

2.4

38.75

41.99

u/l

2.88

616

952

Pacemaker

1600

5734

2.74

277.71

3.1

1.7

37.34

38.83

u/l

1.77

1334

4925

Hypercalcemia

435

689

8.10

275.99

3.4

1.9

40.33

39.54

u/l

0.25

387

605

ILD medications: azathioprine

776

1973

4.28

275.06

4.0

1.4

37.40

40.56

u/l

3.86

714

1751

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

3649

13000

1.95

272.33

2.1

2.0

39.45

40.00

u/l

0.77

3220

11737

Other bacterial diseases, including avohilmo

4053

13740

1.90

272.27

2.0

2.1

39.08

40.16

u/l

2.31

3598

12413

Examination and observation for other reasons

2241

5420

2.41

271.29

2.1

1.9

39.83

39.63

u/l

0.15

2018

4852

Condition for Implicit Sepsis (Organ dysfunction codes)

3463

12523

1.98

268.79

2.1

2.0

39.23

39.98

u/l

1.17

3044

11253

Other bacterial diseases

3784

13436

1.92

268.35

2.0

2.1

38.87

40.12

u/l

2.70

3336

12073

Conduction disorders

1353

3824

3.00

268.29

3.1

1.7

38.08

39.83

u/l

2.05

1148

3430

Influenza and pneumonia

4197

14371

1.85

262.41

2.1

2.0

39.09

40.09

u/l

2.23

3755

13001

1980

8671

2.37

258.17

2.1

2.0

38.65

40.04

u/l

2.28

1776

7794

Other disorders of lacrimal gland

1746

7347

2.51

256.42

2.6

2.0

40.16

39.80

u/l

0.31

1585

6527

Chorioretinal inflammation

343

459

10.21

255.81

3.0

2.0

41.56

38.67

u/l

1.37

321

415

Asthma, including avohilmo

4603

14468

1.80

255.05

2.1

2.0

39.16

39.88

u/l

1.44

4171

12956

Pneumonias (Asthma/COPD co-morbidities)

4017

14576

1.85

253.45

2.1

2.0

38.93

40.14

u/l

3.00

3590

13162

Oedema, not elsewhere classified

1358

4955

2.81

252.31

2.1

1.8

40.65

39.30

u/l

1.39

1180

4332

Pain in limb

3248

10712

1.99

251.05

2.0

39.49

39.62

u/l

0.13

2914

9643

Pneumonia, organism unspecified

3655

13627

1.89

249.92

2.0

38.91

40.15

u/l

2.86

3244

12284

All pneumoniae

4026

14605

1.84

249.59

2.1

2.0

38.94

40.12

u/l

2.84

3598

13194

Neurological diseases, wide definition

1061

1521

3.64

248.99

2.0

2.2

39.00

41.75

u/l

3.36

984

1424

Azathioprine

776

2126

3.97

247.59

4.0

1.5

37.40

40.27

u/l

3.30

714

1903

Symptoms and signs involving the nervous and musculoskeletal systems

2450

11998

2.12

245.71

1.8

2.0

39.51

39.57

u/l

0.05

2223

10641

Other arrhythmias

2550

9263

2.13

245.02

2.5

1.9

39.25

40.37

u/l

1.90

2241

8508

Persons encountering health services for specific procedures and health care

4179

13939

1.82

243.43

2.3

2.0

39.17

39.95

u/l

1.50

3744

12606

Disorders of lacrimal system

1987

8870

2.31

242.91

2.6

2.0

40.11

39.82

u/l

0.26

1803

7890

Hypertensive diseases (excluding secondary)

2039

5152

2.39

242.80

2.2

2.0

38.71

41.47

u/l

6.16

1810

4904

Other and unspecified iridocyclitis

421

730

7.03

241.84

2.0

39.86

38.96

u/l

0.37

388

646

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

3916

14627

1.83

240.46

2.1

2.0

38.96

40.14

u/l

2.83

3486

13211

Disturbances of skin sensation

1399

5482

2.72

239.97

1.9

2.1

39.20

39.69

u/l

0.41

1285

4964

Other special examinations and investigations of persons without complaint or reported diagnosis

2351

5442

2.25

238.02

2.0

1.9

39.51

39.59

u/l

0.06

2127

4869

Obesity related asthma

1624

6852

2.50

237.07

2.3

2.0

38.48

39.90

u/l

2.05

1465

6114

Cardiomyopathies, Primary/intrinsic

669

1708

4.31

236.89

2.1

1.7

32.66

39.89

u/l

10.50

455

1534

Other diseases of pleura

1856

7117

2.37

236.31

1.7

1.9

37.29

39.18

u/l

3.19

1625

6179

Diseases of liver

1619

6842

2.50

235.69

2.0

44.31

39.15

u/l

14.09

1461

6080

AV-block

846

2105

3.67

234.54

3.5

1.6

37.99

38.92

u/l

0.56

735

1854

Neurological diseases

3073

7908

2.00

231.16

2.0

39.16

40.24

u/l

2.03

2784

7120

Tramadol

3125

9872

1.96

230.29

2.0

2.1

39.92

39.85

u/l

0.06

2780

8886

Percutaneous Coronary Intervention

3106

9940

1.97

229.41

2.4

2.0

38.42

40.59

u/l

6.07

2629

9015

Heart failure and coronary heart disease

1723

5120

2.47

228.54

2.0

1.8

36.11

39.44

u/l

6.54

1332

4508

Disorders of other endocrine glands

1903

8556

2.29

228.36

1.9

2.0

39.73

39.78

u/l

0.03

1686

7678

Acute renal failure

1028

3519

3.12

228.10

2.3

1.7

38.91

38.94

u/l

0.01

900

3044

Coronary revascularization (ANGIO or CABG)

3094

9949

1.95

224.41

2.4

2.0

38.45

40.59

u/l

5.94

2619

9023

Hard cardiovascular diseases

3249

10350

1.91

221.35

2.4

2.1

38.26

40.72

u/l

7.97

2779

9457

Cardiomyopathy (excluding other)

675

1831

4.04

219.29

2.1

1.7

32.68

39.67

u/l

10.06

460

1645

Visual disturbances and blindness

2197

10776

2.12

219.13

2.0

39.30

39.65

u/l

0.35

1963

9596

Diseases of the eye and adnexa

2896

7452

2.00

216.61

2.1

2.0

39.70

39.69

u/l

0.01

2681

6713

ILD, hospital admissions 3, with pneumonia sepsis

518

1170

4.97

216.57

1.8

37.37

39.26

u/l

1.09

475

1003

Emergency coronary revascularization (for ACS)

3261

10720

1.89

216.32

2.4

2.0

38.43

40.45

u/l

5.53

2752

9670

Disorders of eyelid, lacrimal system and orbit

3407

13959

1.84

215.92

2.3

2.0

39.62

u/l

0.00

3072

12450

Disorders of thyroid, IBD co-morbidities

675

1154

4.20

213.87

2.4

2.3

38.56

41.79

u/l

2.97

604

1067

Ischemic heart diseases

3202

10358

1.90

213.35

2.4

2.0

38.19

40.62

u/l

7.79

2731

9416

Non-ischemic cardiomyopathy

1332

4200

2.65

209.72

2.1

1.9

36.06

39.81

u/l

6.62

1058

3729

Implicit bacterial Sepsis, including avohilmo

1852

7117

2.25

208.71

1.9

38.46

39.33

u/l

0.89

1588

6237

Pain, not elsewhere classified

1149

4359

2.76

208.20

1.9

38.59

39.52

u/l

0.82

1049

3894

Nonischemic cardiomyopathy

593

1529

4.31

207.87

2.2

1.9

34.23

39.83

u/l

5.51

423

1362

Abnormalities of heart beat

1409

5697

2.50

207.64

2.3

1.9

39.58

39.46

u/l

0.07

1264

5078

Visual disturbances

2049

10016

2.13

207.17

1.9

2.0

39.30

39.65

u/l

0.34

1842

8926

Major coronary heart disease event

3196

10541

1.87

203.52

2.4

2.0

38.43

40.52

u/l

5.86

2711

9543

Diseases of oesophagus, stomach and duodenum

4014

13950

1.74

203.11

2.0

2.1

39.74

39.68

u/l

0.06

3604

12551

Undetermined asthma, excluding more controls

564

1416

4.25

201.72

1.9

1.2

37.45

39.31

u/l

1.20

492

1258

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

3716

13608

1.77

201.70

2.4

2.0

39.09

39.91

u/l

1.46

3290

12328

Metabolic disorders

3601

12378

1.79

201.28

2.1

38.80

40.17

u/l

3.26

3165

11241

Bacterial Sepsis

1874

7325

2.20

198.82

1.9

38.51

39.33

u/l

0.83

1609

6428

Low back pain

2966

10945

1.88

198.56

1.9

2.1

39.99

39.53

u/l

0.56

2670

9822

Other necrotizing vasculopathies (FG)

398

780

5.87

197.98

1.7

2.1

34.22

39.45

u/l

5.72

361

677

Implicit bacterial Sepsis

1676

6547

2.29

196.77

1.9

38.42

39.39

u/l

0.95

1433

5725

Any reimbursement code in KELA

2055

4828

2.19

195.18

2.0

2.1

39.20

41.26

u/l

4.28

1890

4503

COPD/asthma/ILD related infections

3686

10610

1.78

194.96

2.0

38.90

40.28

u/l

3.56

3311

9545

COPD/asthma related infections

3686

10610

1.78

194.96

2.0

38.90

40.28

u/l

3.56

3311

9545

Adjustment and management of implanted device

812

2657

3.26

194.90

4.0

1.8

38.00

38.70

u/l

0.37

656

2276

Nerve, nerve root and plexus disorders

4030

14448

1.72

194.59

2.1

2.0

40.09

39.58

u/l

0.78

3621

12924

Implicit viral Sepsis, including avohilmo

1309

5487

2.50

192.17

2.2

1.8

38.36

39.39

u/l

0.91

1155

4846

Dorsalgia

3636

11122

1.77

191.93

2.0

2.1

39.94

39.54

u/l

0.51

3290

9986

Other joint disorders

3140

9038

1.86

191.36

2.0

39.90

39.95

u/l

0.04

2861

8166

Non-allergic asthma (mode), excluding more controls

680

1992

3.55

190.27

2.2

1.2

39.88

39.37

u/l

0.25

612

1757

Sleep apnoea

3612

13360

1.75

188.13

2.3

2.0

39.71

39.86

u/l

0.16

3215

11979

Other and unspecified dermatitis

2139

10988

2.02

187.55

2.2

2.0

40.33

39.66

u/l

0.76

1940

9799

General examination and investigation of persons without complaint and reported diagnosis

2150

5441

2.11

186.86

2.0

1.9

40.56

39.60

u/l

1.12

1951

4868

Other necrotizing vasculopathies

459

1066

4.91

186.48

1.7

1.9

34.24

38.99

u/l

5.83

416

934

Undetermined asthma

564

1503

4.00

185.66

1.9

1.2

37.45

39.17

u/l

1.06

492

1307

Atrial fibrillation and flutter

1209

3058

2.66

184.50

2.4

2.0

39.51

41.99

u/l

3.10

1051

2876

Other symptoms and signs involving the nervous and musculoskeletal systems

1749

8424

2.17

184.07

1.9

2.0

39.37

39.58

u/l

0.17

1615

7528

Paroxysmal tachycardia

929

2738

2.97

183.59

3.0

1.8

38.08

41.52

u/l

5.10

820

2571

Asthma-related pneumonia

1454

6489

2.33

183.39

2.1

1.9

38.42

39.57

u/l

1.27

1284

5676

Asthma-related pneumonia or sepsis

1455

6499

2.33

183.11

2.1

1.9

38.43

39.56

u/l

1.22

1285

5685

Asthma, hospital admissions 3, pneumonia

1455

6499

2.33

183.11

2.1

1.9

38.43

39.56

u/l

1.22

1285

5685

Dermatitis

2473

13143

1.90

181.53

2.2

2.0

40.00

39.64

u/l

0.37

2241

11721

Gout

1090

3662

2.68

179.66

1.9

37.50

39.06

u/l

1.41

932

3139

Aplastic and other anaemias

1788

7961

2.13

179.59

1.7

1.9

39.45

39.00

u/l

0.32

1536

6954

Asthma/COPD (KELA code 203)

3521

13918

1.73

179.49

2.0

38.46

39.96

u/l

4.23

3179

12493

Arthropathies

3169

9041

1.81

177.99

2.0

39.35

39.94

u/l

0.86

2901

8169

L04AA Selective immunosuppressants

1075

4312

2.66

176.29

2.0

2.1

38.63

40.16

u/l

1.63

987

3887

Sleep apnoea, including avohilmo

3733

13598

1.70

174.71

2.3

2.0

39.97

39.79

u/l

0.20

3321

12227

Episodal and paroxysmal disorders

3847

11723

1.70

173.93

2.1

2.0

39.35

39.91

u/l

0.87

3483

10504

Codeine

3371

10608

1.76

173.60

2.1

39.43

39.83

u/l

0.50

3036

9587

Non-invasive ventilation

991

3248

2.75

173.40

2.0

1.9

38.38

41.05

u/l

3.78

894

3038

Other and unspecified anaemias

1649

7419

2.17

173.27

1.7

1.9

39.52

39.02

u/l

0.36

1410

6470

Other anaemias

1662

7477

2.16

173.21

1.7

1.9

39.45

39.02

u/l

0.30

1422

6522

Opioids

3518

10699

1.74

171.97

2.0

2.1

39.41

39.80

u/l

0.53

3178

9675

Non-allergic asthma (mode)

680

2124

3.32

171.69

2.2

1.2

39.87

39.12

u/l

0.40

612

1840

Hypertension, essential

2867

9069

1.84

171.39

2.2

2.1

39.06

41.00

u/l

4.57

2533

8384

Allergic asthma (mode), excluding more controls

802

2712

3.00

170.71

2.0

1.2

39.00

39.41

u/l

0.24

746

2477

Cardiomyopathy, other and unspecified

445

1079

4.59

169.79

3.6

1.6

34.79

39.74

u/l

4.26

346

967

Certain infectious and parasitic diseases

3392

9960

1.74

167.19

2.0

39.48

39.79

u/l

0.36

3034

9020

Erythema nodosum

272

444

7.66

167.00

2.9

2.1

40.70

39.32

u/l

0.47

254

404

Syncope and collapse

1547

6057

2.20

166.89

2.0

1.8

39.44

39.23

u/l

0.13

1354

5322

Pleural effusion

707

2342

3.24

166.70

1.7

1.8

36.87

38.98

u/l

1.64

604

2018

Heart failure and bmi 25plus

1382

4064

2.38

166.58

2.1

2.0

36.05

39.22

u/l

5.14

1078

3571

Idiopathic pulmonary fibrosis

432

1045

4.62

165.48

1.6

1.8

37.53

38.56

u/l

0.42

392

879

Dermatitis and eczema

4098

15163

1.63

164.78

2.1

2.0

39.78

39.65

u/l

0.15

3723

13562

Diseases of the respiratory system

2129

5432

2.01

163.08

1.9

2.0

39.30

40.46

u/l

1.68

1929

4851

Dilated cardiomyopathy

612

1907

3.52

161.48

2.1

1.9

31.84

39.08

u/l

10.28

409

1666

Haemorrhage from respiratory passages

1237

4783

2.37

160.98

1.9

1.8

39.25

39.05

u/l

0.11

1068

4185

4031

12681

1.64

160.87

2.0

39.14

40.01

u/l

1.79

3620

11339

Disorders of parathyroid gland

907

3462

2.75

159.77

1.8

2.0

39.15

39.53

u/l

0.21

773

3036

Hypothyroidism (congenital or acquired)

884

1729

2.97

158.72

2.1

2.0

40.09

40.98

u/l

0.60

819

1667

Hypertensive diseases

2866

9255

1.79

158.59

2.2

2.1

39.09

41.00

u/l

4.48

2532

8558

Allergic asthma (mode)

802

2833

2.87

157.57

2.0

1.2

39.00

39.14

u/l

0.07

746

2549

Hypertension

2861

9250

1.79

157.57

2.2

2.1

39.09

41.01

u/l

4.49

2528

8553

Atrial fibrillation and flutter with reimbursement

967

2307

2.76

157.06

2.5

1.9

39.16

41.65

u/l

2.61

820

2153

Hypothyroidism, levothyroxine purchases

877

1722

2.96

156.76

2.2

2.0

40.00

40.96

u/l

0.66

813

1660

Hypothyroidism and >3 levothyroxin purchases

877

1722

2.96

156.76

2.2

2.0

40.00

40.96

u/l

0.66

813

1660

Gastro-oesophageal reflux disease

2562

12332

1.80

155.77

1.9

2.1

39.57

39.64

u/l

0.06

2287

11048

Codeine or tramadol medication

4064

13896

1.62

155.72

2.1

2.0

39.36

39.76

u/l

0.57

3637

12502

Other diseases of liver

888

3461

2.74

154.78

2.1

2.0

43.21

39.54

u/l

5.09

801

3094

Endocrine, nutritional and metabolic diseases

2726

7748

1.82

154.48

2.1

2.0

39.80

40.16

u/l

0.38

2472

7183

Other diseases of intestines

3805

13184

1.64

153.88

2.0

2.1

39.66

39.87

u/l

0.24

3426

11920

Antihypertensive medication - note that there are other indications

2103

5722

1.97

153.08

2.1

1.9

38.84

41.48

u/l

6.90

1919

5487

Lower back pain or/and sciatica

3926

15409

1.62

152.89

2.0

39.98

39.60

u/l

0.53

3538

13820

Persons encountering health services for other counselling and medical advice, not elsewhere classified

3944

13145

1.63

152.51

2.0

39.74

39.71

u/l

0.03

3552

11773

Viral Sepsis

893

3523

2.67

150.52

2.4

1.8

37.95

39.74

u/l

1.56

800

3108

Persons encountering health services in other circumstances, wide

4050

13163

1.61

150.31

2.1

2.0

39.74

39.69

u/l

0.05

3637

11785

Presence of cardiac and vascular implants and grafts

1587

5712

2.12

150.25

3.0

1.8

37.76

39.01

u/l

1.36

1301

4953

Gout, FINNGEN

1090

4673

2.42

150.22

1.9

1.8

37.50

38.79

u/l

1.12

932

4010

Soft tissue disorders

3509

10971

1.67

149.62

2.0

39.45

39.66

u/l

0.24

3152

9884

Implicit viral Sepsis

889

3516

2.67

149.07

2.4

1.8

37.96

39.74

u/l

1.53

796

3102

Other dorsopathies, not elsewhere classified

3502

11148

1.67

147.68

2.0

2.1

39.87

39.54

u/l

0.39

3165

10011

Spondylopathies

2798

9645

1.76

146.88

1.9

2.1

39.58

u/l

0.00

2499

8583

Polymyalgia rheumatica

598

1939

3.31

146.45

1.4

1.9

34.43

39.19

u/l

7.21

532

1654

Eosinophilic disease (BM)

147

131

14.45

146.38

1.6

1.2

41.80

40.93

u/l

0.13

137

112

Migraine

1923

7944

1.94

145.63

2.2

2.0

38.59

40.07

u/l

2.78

1812

7242

Liquid cancers

1186

5075

2.31

145.39

1.8

1.9

39.78

39.15

u/l

0.43

1063

4412

Unspecified kidney failure

493

1426

3.74

145.17

2.7

1.8

40.77

38.25

u/l

1.58

441

1216

Diseases of the musculoskeletal system and connective tissue

1744

4316

2.07

145.16

2.0

2.1

39.44

39.97

u/l

0.46

1603

3911

Glomerular diseases

809

3130

2.75

142.90

1.8

1.9

39.02

39.37

u/l

0.16

697

2771

Persons encountering health services for examination and investigation

2058

5442

1.94

142.56

1.9

39.84

39.59

u/l

0.19

1851

4869

Parasetamol

2446

6921

1.82

141.26

2.0

2.1

39.25

40.44

u/l

1.93

2221

6307

Rheumatoid arthritis

1196

4829

2.28

141.07

1.7

2.0

38.35

39.77

u/l

1.58

1067

4272

Hyperparathyroidism

782

2955

2.78

140.80

1.8

1.9

39.15

39.44

u/l

0.14

669

2584

Cerebrovascular diseases (FINNGEN)

1112

3386

2.39

139.31

1.8

2.0

38.62

41.88

u/l

5.08

957

3188

Symptoms and signs involving cognition, perception, emotional state and behaviour

3485

14710

1.62

137.54

2.0

2.1

38.91

39.86

u/l

1.92

3104

13242

Urticaria and erythema

1465

7363

2.07

137.33

2.2

2.0

41.39

39.69

u/l

2.59

1334

6666

Primary_lymphoid and hematopoietic malignant neoplasms

970

4165

2.45

136.27

1.8

1.9

40.49

39.11

u/l

1.08

876

3619

Covid-19 confirmed case

1420

7072

2.08

135.87

2.0

1.9

37.31

39.33

u/l

3.36

1265

6236

Scleritis

166

200

11.72

135.59

1.7

2.6

35.42

39.46

u/l

1.57

159

183

Diseases of the skin and subcutaneous tissue

3365

10454

1.65

135.16

2.1

2.0

40.16

39.28

u/l

1.54

3037

9359

Demyelinating diseases of the central nervous system

491

1494

3.63

135.07

1.5

2.1

36.57

40.00

u/l

3.60

459

1378

Myalgia

1006

4402

2.39

134.80

2.0

39.92

39.65

u/l

0.16

904

3995

Provisional assignment of new diseases of uncertain etiology

1979

10980

1.84

132.46

2.0

37.83

39.57

u/l

3.59

1774

9820

Sicca syndrome [Sjögren]

456

1341

3.75

132.25

2.0

2.1

40.27

40.66

u/l

0.14

418

1196

Codes for special purposes

1980

10996

1.84

132.06

2.0

37.84

39.56

u/l

3.54

1775

9836

Pain (limb, back, neck, head abdominally)

2347

6645

1.81

131.16

1.9

2.0

39.61

39.89

u/l

0.24

2113

5899

Sulfasalazine

1015

4502

2.34

131.05

1.6

1.5

37.41

40.09

u/l

4.50

906

3988

Chronic sinusitis

1623

8571

1.96

130.64

2.2

2.1

39.14

40.01

u/l

1.02

1481

7704

Scleritis and episcleritis

379

995

4.28

130.53

1.7

2.0

36.58

39.48

u/l

2.17

354

907

Bronchitis

3855

15053

1.57

130.48

2.0

39.40

39.83

u/l

0.62

3475

13498

Hypothyroidism, strict autoimmune

2336

8830

1.77

130.36

2.1

2.0

40.26

39.56

u/l

0.86

2124

7852

Liquid cancers, including Hilmo

1379

6050

2.09

129.92

1.8

1.9

39.72

39.34

u/l

0.25

1231

5298

Dorsopathies

3486

11164

1.61

128.75

2.0

2.1

39.97

39.55

u/l

0.55

3149

10027

Other headache syndromes

1564

8179

1.97

128.60

2.0

40.27

40.10

u/l

0.12

1434

7357

Depression medications

925

1836

2.61

127.95

2.0

40.52

41.26

u/l

0.48

857

1774

Other disorders of skin and subcutaneous tissue

2611

13388

1.69

126.25

2.2

2.0

40.41

39.46

u/l

1.44

2314

11924

Other intervertebral disc disorders

2857

10425

1.67

125.30

2.0

2.1

40.14

39.60

u/l

0.69

2569

9327

Dialysis, with operation codes

573

2016

3.05

121.92

1.8

39.56

39.41

u/l

0.05

514

1775

Diabetes mellitus

3569

13372

1.57

121.85

2.3

2.0

39.49

40.10

u/l

0.85

3089

12237

Nonalcoholic fatty liver disease

537

1837

3.18

121.00

2.2

2.0

43.54

39.85

u/l

3.37

492

1662

Acute upper respiratory infections

3610

14116

1.56

120.97

2.0

39.42

39.80

u/l

0.52

3269

12597

Diabetes, varying definitions

3550

13367

1.57

120.77

2.3

2.0

39.44

40.12

u/l

1.00

3071

12231

Care involving dialysis

411

1198

3.76

120.59

1.7

1.9

39.15

39.51

u/l

0.12

373

1056

Subjective visual disturbances

1059

4965

2.23

120.33

2.1

2.0

39.78

39.43

u/l

0.22

958

4434

COPD (mode)

862

2813

2.46

119.84

1.7

1.2

37.46

38.18

u/l

0.42

727

2394

Complications of surgical and medical care, not elsewhere classified

3488

15175

1.56

119.81

2.1

2.0

39.49

39.73

u/l

0.26

3108

13615

Type 2 diabetes

3450

12912

1.58

119.80

2.3

2.0

39.12

40.07

u/l

1.61

2982

11794

Septicaemia

1465

6991

1.97

119.39

2.0

1.9

39.01

39.53

u/l

0.37

1274

6137

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

1463

4722

2.01

117.48

2.2

2.0

40.64

41.40

u/l

0.67

1335

4490

Continuous positive airway pressure

700

2259

2.70

117.19

2.6

2.0

37.53

41.31

u/l

4.88

596

2089

Gout, idiopatic and unspecified

935

4217

2.32

116.82

1.9

1.8

37.68

38.58

u/l

0.60

790

3638

Symptoms and signs involving the digestive system and abdomen

3336

10706

1.59

116.60

2.0

2.1

39.68

39.90

u/l

0.23

3018

9571

Explicit Sepsis

1536

7503

1.92

116.16

2.0

1.9

38.93

39.45

u/l

0.39

1341

6621

Small fibre neuropathy

232

458

6.09

116.14

2.0

2.1

39.09

38.90

u/l

0.04

207

409

Dizziness and giddiness

2658

12840

1.65

115.92

2.0

39.27

39.76

u/l

0.61

2346

11491

Explicit Sepsis, including avohilmo

1567

7675

1.91

115.69

2.0

1.9

38.97

39.46

u/l

0.36

1367

6776

Disorders of optic nerve and visual pathways

482

1590

3.29

115.52

2.2

2.0

39.58

39.86

u/l

0.10

449

1445

Early onset COPD, excluding more controls

613

2276

2.80

115.42

2.0

1.2

38.20

38.37

u/l

0.07

526

1944

Abnormal findings on diagnostic imaging of central nervous system

299

723

4.64

115.03

1.8

38.77

39.94

u/l

0.44

279

647

Disorders of choroid and retina

2792

12293

1.63

113.55

2.1

2.0

40.51

39.41

u/l

1.81

2467

10887

Gastrointestinal diseases

1917

5337

1.84

113.37

1.9

2.1

39.56

39.59

u/l

0.02

1750

4873

Valvular heart disease excluding rheumatic fever

1520

5761

1.94

113.26

2.0

1.8

38.82

40.31

u/l

1.76

1295

5193

Non-rheumatic valve diseases

1513

5730

1.94

112.74

2.0

1.8

38.82

40.28

u/l

1.72

1289

5166

Symptoms and signs concerning food and fluid intake

439

1381

3.37

112.13

1.6

1.7

38.62

39.24

u/l

0.20

388

1220

Other nutritional deficiencies

2444

13795

1.66

111.95

2.1

39.26

39.78

u/l

0.58

2177

12476

Sleep disorders (combined)

3713

12870

1.53

111.84

2.1

2.0

39.85

39.67

u/l

0.20

3292

11572

Nutritional anaemias

1746

9421

1.82

111.72

1.9

38.78

39.39

u/l

0.55

1505

8321

Fibromyalgia

466

1537

3.27

111.31

1.9

2.1

40.67

40.35

u/l

0.12

412

1436

Diseases of arteries, arterioles and capillaries (FINNGEN)

824

2393

2.47

110.47

1.9

38.82

41.70

u/l

2.90

705

2241

Abdominal and pelvic pain

3294

10706

1.57

109.99

2.0

2.1

39.51

39.90

u/l

0.48

2979

9571

Acute sinusitis

1927

10227

1.76

109.65

2.2

2.1

39.04

40.08

u/l

1.46

1738

9275

Osteopathies and chondropathies

2013

10887

1.74

109.27

2.3

2.0

39.72

39.79

u/l

0.05

1784

9698

Certain infectious and parasitic diseases, including avohilmo

2327

6936

1.71

108.85

2.0

39.37

39.83

u/l

0.46

2063

6271

Secondary hypertension

346

947

3.86

107.55

1.9

1.8

38.85

41.81

u/l

1.86

311

884

Factors influencing health status and contact with health services

911

1950

2.40

107.52

2.1

1.9

39.33

39.35

u/l

0.01

811

1764

Iron deficiency anaemia

1525

8247

1.87

107.22

1.9

39.07

39.53

u/l

0.34

1319

7292

Type 2 diabetes, wide definition

2690

10670

1.62

107.19

2.2

2.0

38.75

40.35

u/l

3.06

2326

9638

Other septicaemia, including avohilmo

1316

6493

1.96

106.50

2.1

1.9

38.87

39.48

u/l

0.42

1144

5688

Erysipelas, including avohilmo

2472

11391

1.64

106.27

2.0

2.1

39.68

40.00

u/l

0.28

2143

10169

Other specified/unspecified systemic involvement of connective tissue

325

886

4.09

106.04

1.7

2.1

39.95

39.84

u/l

0.03

300

795

Glomerular disorders in diseases classified elsewhere

532

1941

2.94

105.96

1.8

1.9

40.21

39.23

u/l

0.41

458

1710

Hypothyroidism, drug reimbursement

492

1130

3.17

105.43

2.0

37.74

41.65

u/l

3.95

453

1085

Other diseases of pericardium

256

587

4.88

105.30

1.8

1.7

35.79

40.22

u/l

2.42

223

523

Other septicaemia

1289

6373

1.97

105.23

2.1

1.9

38.81

39.49

u/l

0.48

1121

5580

Sciatica+with lumbago

1826

9412

1.76

104.51

2.0

2.1

40.05

39.71

u/l

0.29

1667

8434

Abnormal results of function studies

415

1329

3.37

104.18

2.0

1.7

42.73

39.67

u/l

2.05

377

1190

Acute upper respiratory infections of multiple and unspecified sites

2655

12310

1.60

103.84

2.0

2.1

39.74

39.99

u/l

0.25

2419

11064

Disorders of lipoprotein metabolism and other lipidaemias

2795

10854

1.60

103.53

2.0

2.1

38.40

40.23

u/l

4.37

2418

9765

Gout, unspecified

775

3405

2.39

103.32

2.0

1.8

37.81

38.69

u/l

0.51

654

2934

Other diseases of blood and blood-forming organs, wide

888

4130

2.26

103.28

1.9

2.0

41.38

39.54

u/l

1.45

797

3656

Intracranial trauma

1779

6868

1.78

102.56

2.0

2.1

41.22

40.37

u/l

0.84

1585

6227

Other/unspecified dorsalgia

1329

7039

1.92

102.07

2.0

2.1

39.68

39.62

u/l

0.04

1196

6313

Primary hyperparathyroidism

514

1883

2.94

101.89

1.6

2.0

38.92

39.81

u/l

0.44

432

1665

Type 2 diabetes, definitions combined

3238

12457

1.54

101.74

2.3

2.0

38.55

40.14

u/l

3.74

2783

11357

MS-disease / Multiple Sclerosis

395

1252

3.46

101.71

1.4

2.2

36.33

40.16

u/l

3.67

369

1151

Care involving use of rehabilitation procedures

2171

11998

1.66

101.22

2.0

39.57

40.00

u/l

0.43

1954

10781

Other and unspecified iron deficiency

1232

6475

1.96

100.64

2.0

1.9

39.18

39.56

u/l

0.23

1073

5728

Other diseases of upper respiratory tract

3584

12578

1.51

100.38

2.0

39.56

39.83

u/l

0.33

3224

11225

Complications of medical and surgical care

2553

14705

1.59

99.91

2.1

2.0

39.05

39.70

u/l

0.85

2259

13155

Type 2 diabetes, definitions combined, including avohilmo

3243

12471

1.53

98.99

2.3

2.0

38.49

40.14

u/l

4.09

2798

11378

Type 2 diabetes, strict (exclude DM1)

3239

12545

1.53

98.64

2.3

2.0

38.57

40.13

u/l

3.63

2782

11435

Asthma and allergy, excluding more controls

433

1432

3.11

98.61

2.0

1.2

38.41

39.98

u/l

1.02

404

1325

Concussion

1561

6804

1.82

97.88

2.0

2.1

41.50

40.36

u/l

1.19

1395

6168

Vocal cord dysfunction

491

1538

2.93

97.79

2.0

2.2

38.08

41.94

u/l

4.05

437

1434

Bleeding

2767

12608

1.57

97.68

1.9

2.0

39.56

39.67

u/l

0.09

2415

11219

Shoulder lesions

2512

9501

1.62

97.56

1.9

2.1

40.44

39.67

u/l

1.01

2238

8496

Rheumatoid arthritis, including avohilmo

1361

7482

1.88

97.43

1.6

2.0

38.50

39.77

u/l

1.53

1214

6608

Obesity and other hyperalimentation

2277

13487

1.62

96.81

2.2

2.1

39.26

39.77

u/l

0.54

2024

12214

Arthropathies in other diseases classified elsewhere

229

517

5.05

96.69

3.8

2.1

43.85

38.77

u/l

2.50

205

458

Chronic rhinitis, nasopharyngitis and pharyngitis

1203

6371

1.95

96.66

2.1

39.24

40.02

u/l

0.72

1093

5740

Other acute lower respiratory infections

1841

10480

1.71

96.61

2.0

38.72

39.60

u/l

1.07

1626

9369

Non-Hodgkin lymphoma, all, including Hilmo

538

2073

2.75

95.85

1.9

41.90

38.95

u/l

2.19

485

1770

Obesity

2263

13444

1.62

95.63

2.2

2.1

39.28

39.78

u/l

0.53

2012

12173

Caries of dentine

856

3888

2.21

95.00

2.0

2.1

38.93

39.13

u/l

0.10

751

3435

Gout, strict definition

687

2975

2.43

94.87

1.9

1.8

37.66

38.68

u/l

0.55

569

2562

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

262

665

4.39

94.44

2.0

1.9

38.36

39.00

u/l

0.17

220

566

Acute tubulo-interstitial nephritis

2030

10512

1.66

94.30

1.9

39.09

39.34

u/l

0.20

1774

9391

Intestinal infectious diseases, including avohilmo, including avohilmo

3850

14875

1.46

94.24

2.0

40.13

39.63

u/l

0.74

3421

13382

Nephropathy related operations

528

2040

2.77

94.00

1.8

1.9

39.39

39.60

u/l

0.07

476

1797

Eosinophilia

147

233

7.98

93.24

1.6

2.2

41.80

38.98

u/l

0.65

137

211

Asthma and allergy

433

1481

3.00

92.86

2.0

1.2

38.41

39.89

u/l

0.93

404

1356

Dental caries

940

4359

2.11

92.78

2.0

39.22

u/l

0.00

821

3846

Follow-up examination after treatment for conditions other than malignant neoplasms

1305

4658

1.91

92.58

2.1

1.9

40.32

39.57

u/l

0.62

1170

4157

Acute bronchitis

1415

7834

1.82

91.87

2.1

2.0

39.11

39.46

u/l

0.26

1237

6962

Presence of other functional implants

1917

7941

1.69

90.82

2.0

1.9

38.87

39.59

u/l

0.74

1684

6983

Obesity due to excess calories

1728

10366

1.71

90.77

2.1

2.0

39.30

39.76

u/l

0.39

1539

9412

Polyarthrosis

742

3016

2.31

90.47

1.8

2.0

40.01

39.85

u/l

0.07

640

2623

Migraine with aura

919

4537

2.10

90.38

2.1

2.0

38.28

39.97

u/l

1.97

855

4175

Diplopia

558

2255

2.62

90.23

1.8

1.9

38.01

39.49

u/l

0.97

508

2004

STROKE

1800

7223

1.72

89.96

1.9

2.0

38.28

40.95

u/l

5.75

1544

6627

Irritable bowel syndrome

1035

5357

2.00

89.29

1.9

2.0

39.98

39.72

u/l

0.17

940

4835

Other demyelinating diseases of the central nervous system

249

640

4.44

89.07

1.5

2.3

34.44

40.73

u/l

6.75

234

591

Abnormal findings on diagnostic imaging of other body structures

554

2244

2.60

88.74

2.6

1.7

40.07

39.83

u/l

0.09

502

1971

Exclusions for E4_PCOS_BROAD

699

3139

2.34

88.49

2.1

2.0

38.73

39.95

u/l

0.83

644

2844

Other or ill-defined heart diseases

271

737

4.00

87.87

3.9

1.7

36.56

40.96

u/l

2.58

243

669

Other pleural conditions

412

1448

3.03

87.57

1.6

1.8

36.61

38.97

u/l

1.19

354

1228

Complications of procedures, not elsewhere classified

2737

14712

1.53

87.48

2.0

39.54

39.69

u/l

0.13

2429

13181

Spondylosis

1808

8563

1.69

87.28

1.8

2.1

39.85

39.57

u/l

0.23

1626

7567

Hypertensive heart and/or renal disease

858

2986

2.17

87.15

1.6

1.8

37.59

40.51

u/l

3.35

705

2650

Fibrosis and cirrhosis of liver

372

1246

3.24

87.04

2.1

1.9

47.90

38.91

u/l

7.69

334

1101

Other disorders of fluid, electrolyte and acid-base balance

1059

5224

1.97

86.97

1.9

39.44

39.84

u/l

0.22

912

4598

Hernia of abdominal wall, postoperative

609

2568

2.44

86.89

2.1

1.9

39.83

39.67

u/l

0.06

531

2265

Dysphagia

890

4418

2.09

86.45

1.9

39.31

39.24

u/l

0.04

779

3848

Erysipelas

1819

9579

1.67

86.45

2.1

2.0

39.34

39.91

u/l

0.49

1577

8463

Disorders of lens

2210

8661

1.62

86.39

2.2

2.0

39.57

39.86

u/l

0.25

1975

7681

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

3381

15048

1.46

84.98

2.1

2.0

40.00

39.67

u/l

0.40

3022

13535

Disorders of the thyroid gland

3101

13743

1.49

84.81

2.1

2.0

39.69

39.38

u/l

0.34

2813

12263

Neoplasms

2476

8396

1.57

84.18

2.0

39.28

39.90

u/l

0.76

2280

7649

Left bundle-branch block

323

1011

3.43

84.13

2.4

1.6

35.74

39.62

u/l

2.41

254

905

Depression

3226

14892

1.47

84.10

1.9

2.1

40.04

39.85

u/l

0.21

2900

13424

Other antidepressants

3345

11752

1.48

83.92

1.9

2.1

39.57

39.67

u/l

0.10

2989

10542

Mood disorders, excluding more controls

3162

12728

1.48

83.89

1.9

2.1

40.08

39.72

u/l

0.42

2834

11460

Iridocyclitis in diseases classified elsewhere

151

272

6.69

83.56

5.1

2.3

43.22

40.18

u/l

0.79

141

244

Other disorders of optic [2nd] nerve and visual pathways

317

991

3.49

83.44

2.4

2.0

40.05

39.63

u/l

0.12

288

893

Osteoporosis

934

4376

2.03

83.05

2.5

1.9

39.78

39.66

u/l

0.06

803

3813

Arthrosis

2203

7651

1.61

82.39

2.0

2.1

39.50

39.92

u/l

0.40

1984

6848

Persons encountering health services in other circumstances

1398

8042

1.76

82.00

1.9

2.0

40.43

39.57

u/l

0.78

1267

7230

Lumbar disc prolapse

2119

10020

1.60

81.80

2.1

39.99

39.66

u/l

0.30

1907

8976

Giant cell arteritis

227

578

4.40

81.69

1.8

1.9

35.06

40.08

u/l

3.37

200

504

Diverticular disease of intestine

2351

9509

1.57

81.43

2.0

2.1

38.18

39.79

u/l

3.27

2039

8410

Disorders of conjunctiva

2825

14912

1.49

80.95

2.1

2.0

39.57

39.87

u/l

0.35

2576

13423

Mood [affective] disorders

3400

15282

1.45

80.59

1.9

2.1

40.12

39.81

u/l

0.37

3055

13756

Pure hypercholesterolaemia

2433

10154

1.55

80.17

2.0

2.1

38.23

40.25

u/l

4.67

2106

9099

Mood disorders

3403

15295

1.44

79.88

1.9

2.1

40.12

39.81

u/l

0.38

3059

13765

Immunodeficiencies

262

749

3.89

79.86

2.9

2.0

40.60

39.37

u/l

0.39

247

670

Diarrhoea and gastroenteritis of presumed infectious origin

2362

13953

1.54

79.82

2.1

2.0

39.56

39.72

u/l

0.14

2068

12589

Other disorders involving the immune mechanism, not elsewhere classified

190

431

5.01

79.78

2.1

1.2

37.25

37.32

u/l

0.01

173

384

Migraine without aura

740

3534

2.17

79.77

2.3

2.0

39.55

40.35

u/l

0.56

699

3304

Intestinal infectious diseases

3126

16164

1.46

79.74

2.0

39.52

39.74

u/l

0.23

2749

14576

Papilloedema, unspecified

164

331

5.80

79.70

2.8

2.2

39.14

38.96

u/l

0.04

148

303

ILD-related respiratory insufficiency

193

444

4.93

79.60

1.8

2.0

38.72

38.60

u/l

0.02

175

383

Later onset COPD, excluding more controls

543

1691

2.53

79.41

1.5

1.2

36.89

37.72

u/l

0.37

460

1392

Other general symptoms and signs

236

619

4.07

79.07

1.9

38.33

40.34

u/l

0.73

222

562

Respiratory insufficiency

262

741

3.71

78.77

1.8

1.2

35.63

39.02

u/l

1.84

225

623

Any operation in hilmo

115

13.21

78.70

2.0

1.1

38.05

34.85

u/l

0.56

103

Other respiratory disorders and diseases

712

3377

2.19

78.41

1.8

36.51

38.97

u/l

2.63

632

2920

Other diseases of the respiratory system

712

3377

2.19

78.41

1.8

36.51

38.97

u/l

2.63

632

2920

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

1733

10434

1.64

76.84

2.0

2.1

39.43

39.91

u/l

0.47

1572

9341

Other arthrosis

1655

6746

1.68

76.47

2.0

2.1

39.96

39.95

u/l

0.01

1490

5995

Immunodeficiency with predominantly antibody defects

167

354

5.44

76.40

2.7

1.2

40.57

38.23

u/l

0.68

154

319

Nausea and vomiting

897

4549

1.98

75.62

2.0

1.9

39.43

39.57

u/l

0.07

790

4005

Transplanted organ and tissue status

409

1551

2.81

75.53

1.9

1.8

39.95

39.89

u/l

0.02

373

1391

Other CVD (FINNGEN)

401

1104

2.90

75.50

2.0

1.8

39.33

41.03

u/l

0.80

331

1024

Other cataract

1450

6394

1.73

75.45

2.2

2.0

40.04

39.47

u/l

0.45

1275

5621

Extracorporeal dialysis

298

956

3.41

75.39

1.6

1.9

38.64

38.68

u/l

0.01

271

846

Other disorders of eye and adnexa

586

2620

2.35

75.38

2.3

2.0

37.79

39.73

u/l

1.68

544

2372

Anxiety disorders, excluding more controls

2766

12084

1.49

75.33

2.0

2.1

39.83

39.89

u/l

0.05

2503

10922

Disorders of synovium and tendon

1753

9316

1.63

75.03

2.0

2.1

40.31

39.78

u/l

0.51

1589

8375

Hypothyroidism, other/unspecified

2845

12890

1.47

74.71

2.1

2.0

39.98

39.39

u/l

0.79

2585

11525

Diseases of salivary glands

1176

6706

1.81

74.67

2.1

2.0

39.51

39.52

u/l

0.01

1067

6010

Other disorders of white blood cells

280

871

3.53

74.62

2.1

1.9

41.41

38.63

u/l

1.07

254

775

Symptoms and signs involving the urinary system

2469

12549

1.51

74.53

1.8

2.0

38.43

39.82

u/l

2.58

2183

11148

Seropositive rheumatoid arthritis

789

3940

2.06

74.07

1.6

2.1

38.11

40.26

u/l

2.11

691

3462

Other retinal disorders

2036

10050

1.57

73.20

2.0

1.9

40.61

39.20

u/l

2.05

1773

8839

Pulmonary heart disease, diseases of pulmonary circulation

1053

5860

1.85

72.36

2.0

1.9

38.47

39.22

u/l

0.52

926

5104

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

3019

12512

1.45

72.34

2.2

2.0

39.43

40.25

u/l

1.15

2631

11414

Other disorders of urethra and urinary system

2281

10566

1.53

71.98

1.9

2.0

40.03

39.56

u/l

0.50

2030

9457

All influenza

864

4529

1.97

71.61

2.2

2.0

39.39

40.03

u/l

0.39

760

4022

Depression or dysthymia

2180

7789

1.56

71.21

1.9

2.1

40.05

39.54

u/l

0.50

1934

6973

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2004

12914

1.55

71.18

2.0

39.02

39.65

u/l

0.69

1770

11517

Neurotic, stress-related and somatoform disorders

2955

14298

1.45

70.74

2.0

2.1

39.74

40.04

u/l

0.35

2688

12921

Benign neoplasms

3131

11992

1.44

70.72

2.0

39.23

39.72

u/l

0.67

2830

10837

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

2982

16391

1.44

70.68

2.2

2.0

39.73

39.74

u/l

0.01

2700

14712

Coagulation defects, purpura and other haemorrhagic conditions

722

3584

2.10

70.66

2.1

1.9

42.08

39.21

u/l

2.39

647

3192

SLE (Finngen)

181

434

4.63

70.34

1.7

2.2

40.07

40.24

u/l

0.03

165

391

Anxiety disorders

2975

14378

1.44

70.01

2.0

2.1

39.80

40.02

u/l

0.24

2705

12988

Hypothyreosis and Thyroxine purchase for inclusion criteria

2945

13555

1.45

69.68

2.1

2.0

39.99

39.43

u/l

0.75

2677

12117

Keratitis

1195

6989

1.76

69.09

2.2

2.0

40.43

39.58

u/l

0.71

1084

6242

Other functional intestinal disorders

1465

8166

1.66

69.09

1.8

2.0

39.47

39.50

u/l

0.02

1309

7257

Episcleritis

266

840

3.46

69.00

1.7

2.1

36.50

39.42

u/l

1.69

247

772

Spinal stenosis

1567

7158

1.65

68.61

2.0

39.74

39.35

u/l

0.28

1377

6228

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

170

398

4.83

68.57

1.8

1.2

37.10

36.91

u/l

0.04

155

356

Spondylopathies (FG)

504

2198

2.40

68.44

1.9

2.1

38.31

40.10

u/l

1.34

463

1993

Other neurological diseases

2299

12063

1.50

68.44

1.9

2.0

38.50

39.57

u/l

1.74

2029

10642

Disorders of gallbladder, biliary tract and pancreas

3190

14175

1.42

68.34

2.0

2.1

39.78

39.63

u/l

0.14

2844

12695

Coxibs

849

2256

2.02

67.29

1.7

2.0

38.21

38.42

u/l

0.10

766

1968

Senile cataract

1933

7634

1.57

66.94

2.1

2.0

39.54

39.63

u/l

0.07

1717

6714

Pericarditis

177

433

4.49

66.84

2.0

1.6

35.72

40.75

u/l

2.21

163

396

Noninfective enteritis and colitis

1533

9619

1.63

66.83

1.8

2.1

39.15

39.84

u/l

0.65

1351

8663

Hyperlipidaemia, other/unspecified

1213

6428

1.74

66.80

1.9

37.67

39.68

u/l

2.49

1010

5652

Reactive arthropathies, FINNGEN

296

1009

3.13

66.77

1.9

2.1

37.23

40.17

u/l

1.77

275

912

Biological medication for rheuma

691

3451

2.09

66.66

1.6

2.1

37.68

40.04

u/l

2.58

649

3166

Ocular pain

381

1492

2.72

66.18

2.5

2.0

36.62

40.06

u/l

2.98

354

1365

Rotator cuff syndrome

1948

8792

1.55

66.17

1.9

2.1

40.23

39.59

u/l

0.67

1737

7819

Spondyloarthritis

624

3004

2.16

66.09

1.9

2.0

38.45

39.73

u/l

0.89

564

2688

Chronic gastritis

860

4630

1.91

65.84

1.8

1.9

39.78

39.12

u/l

0.38

734

4007

Hypertensive Heart Disease

733

2786

2.06

65.72

1.7

1.8

37.62

40.36

u/l

2.62

594

2470

Conjunctivitis (acute, non atopic), including avohilmo

3257

14184

1.41

65.41

2.1

2.0

39.92

39.79

u/l

0.13

2938

12719

Functional dyspepsia

931

5164

1.86

64.89

2.0

41.34

39.51

u/l

1.92

845

4623

Gonarthrosis [arthrosis of knee](FG)

2191

8440

1.52

64.86

2.0

2.2

39.03

40.52

u/l

2.59

1943

7508

Benign neoplasm of colon, rectum, anus and anal canal

2014

11385

1.52

64.60

2.0

39.71

39.48

u/l

0.19

1751

9981

Urticaria

1042

5982

1.79

64.56

2.2

2.1

41.62

39.92

u/l

1.96

944

5435

Rheumatism, unspecified

505

2264

2.34

64.50

2.1

39.81

40.04

u/l

0.10

450

2037

Lung cancer and mesothelioma

485

1781

2.38

64.04

1.7

1.2

37.43

38.48

u/l

0.50

416

1498

Chronic laryngitis and laryngotracheitis

533

2452

2.28

63.91

1.9

41.53

39.66

u/l

1.27

477

2163

L04AD Calcineurin inhibitors

444

1903

2.47

63.42

2.2

2.0

39.66

39.56

u/l

0.03

408

1711

Conjunctivitis

2486

13981

1.45

62.98

2.1

39.67

40.06

u/l

0.44

2274

12628

Implicit fungal Sepsis, including avohilmo

308

1110

2.97

62.95

2.1

2.0

39.59

39.82

u/l

0.06

274

985

Recurrent or chronic depression

1365

5793

1.67

62.42

2.1

2.3

40.26

40.01

u/l

0.16

1232

5291

Secondary right heart disease

201

567

3.89

62.28

1.9

2.0

38.09

38.88

u/l

0.18

177

495

Diabetes medication

3343

14252

1.39

62.07

2.2

2.0

39.54

39.94

u/l

0.47

2919

12919

Genitourinary diseases

1710

5451

1.60

62.05

2.1

39.40

40.25

u/l

0.86

1547

4926

Temporal arteritis

185

497

4.13

61.79

1.7

1.9

34.83

39.56

u/l

2.61

162

433

Other inflammation of eyelid

539

2529

2.23

61.50

2.0

39.10

39.57

u/l

0.21

481

2260

Cirrhosis of liver, NAS

259

863

3.27

61.47

2.1

2.0

49.23

38.57

u/l

6.70

230

754

Purpura and other haemorrhagic conditions

507

2327

2.28

61.19

2.1

1.9

42.18

39.23

u/l

1.78

459

2064

Other pulmonary heart/vessel disease

212

630

3.67

60.56

1.9

2.0

37.96

38.91

u/l

0.24

188

551

Cervical disc disorders

1150

6901

1.71

60.46

2.0

2.1

39.97

39.50

u/l

0.34

1034

6104

Cervicalgia

714

3724

1.98

60.42

1.9

2.0

41.54

39.32

u/l

2.04

629

3325

Preparatory care for dialysis

224

697

3.55

59.97

1.8

2.0

40.46

39.03

u/l

0.45

198

611

Migraine with aura and triptan purchases

596

2929

2.11

59.97

2.2

2.1

38.45

39.79

u/l

1.01

561

2732

Glomerulonephritis

390

1617

2.55

59.96

1.7

1.9

37.94

39.49

u/l

0.69

339

1436

Abnormal serum enzyme levels

956

5273

1.80

59.83

1.8

42.35

38.19

u/l

6.29

851

4593

Secondary and unspecified malignant neoplasm of lymph nodes

340

1324

2.73

59.64

1.9

43.00

38.99

u/l

2.58

311

1147

Other disorders of skin and subcutaneous tissue, not elsewhere classified

518

2423

2.23

59.51

2.1

1.9

40.34

39.15

u/l

0.62

453

2137

Abnormalities of gait and mobility

440

1928

2.40

59.43

1.6

1.8

38.45

38.87

u/l

0.17

376

1658

Viral infections characterized by skin and mucous membrane lesions

1381

8704

1.62

59.37

2.4

2.0

39.17

39.79

u/l

0.54

1241

7798

Other disorders of adrenal gland

223

694

3.51

59.33

2.5

1.9

37.14

39.11

u/l

0.66

205

628

Insulin medication

1881

10464

1.52

59.29

2.2

2.0

41.10

39.84

u/l

1.43

1615

9351

Budesonide

465

2081

2.32

59.25

2.0

1.5

40.25

40.09

u/l

0.06

416

1857

Infections of the skin and subcutaneous tissue

1912

12740

1.50

58.85

2.1

40.31

39.56

u/l

0.80

1701

11490

Bacterial pneumoniae

1233

6618

1.67

58.83

2.1

1.9

37.97

39.67

u/l

2.11

1070

5835

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

537

2563

2.19

58.75

1.8

1.9

48.30

38.70

u/l

12.19

480

2253

Other degenerative diseases of the nervous system

842

3339

1.88

58.70

1.5

1.9

37.50

39.50

u/l

2.17

750

2949

Ischaemic heart disease, wide definition

2387

10244

1.46

58.64

1.9

2.1

38.20

40.22

u/l

4.42

2007

9168

Postprocedural disorders of nervous system

318

1210

2.81

58.62

2.3

2.1

39.25

40.37

u/l

0.47

300

1125

Reactive arthropathies

342

1347

2.68

58.44

1.8

2.0

37.25

39.46

u/l

1.26

314

1208

Diseases of the digestive system

1404

8864

1.60

57.98

1.8

1.9

40.62

39.13

u/l

1.74

1240

7779

Viral pneumonia

457

2053

2.32

57.91

2.2

1.9

37.22

39.42

u/l

1.39

403

1817

Seronegative rheumatoid arthritis

400

1698

2.46

57.90

1.6

2.1

36.82

40.56

u/l

3.61

362

1497

Abnormal weight loss

375

1552

2.56

57.90

1.6

1.9

39.11

39.20

u/l

0.02

329

1355

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1828

12299

1.51

57.66

2.0

38.99

39.58

u/l

0.60

1612

10945

Benign neoplasm: Colon

1690

10509

1.54

57.66

2.0

1.9

39.60

39.31

u/l

0.23

1463

9173

Gonarthrosis

1857

6962

1.53

57.25

2.0

2.1

39.02

39.93

u/l

1.04

1658

6186

Other diseases of urinary system

3072

12567

1.39

57.21

1.9

2.0

38.88

39.64

u/l

1.20

2732

11273

Bacterial pneumonia (organism specified)

1351

7717

1.62

56.99

2.1

1.9

38.22

39.41

u/l

1.27

1179

6772

Bronchiectasis

301

1130

2.83

56.80

2.0

1.9

38.67

39.55

u/l

0.32

263

977

Vasomotor and allergic rhinitis

1215

7336

1.65

56.59

2.1

39.21

40.12

u/l

0.91

1102

6671

Other viral diseases, including avohilmo

1258

7780

1.64

56.30

1.9

2.1

39.45

39.80

u/l

0.24

1181

7107

Bacterial pneumonia, not elsewhere classified

1159

6201

1.68

56.07

2.1

1.9

37.89

39.65

u/l

2.15

1003

5458

Diabetes, insulin treatment (Kela reimbursement)

3179

13943

1.37

55.84

2.2

2.0

39.37

40.06

u/l

0.93

2766

12579

5-aminosalicylic acid

631

3243

2.00

55.54

1.9

1.5

39.10

40.16

u/l

0.66

551

2914

Giant cell arteritis with polymyalgia rheumatica

185

536

3.82

55.37

1.7

1.9

34.83

39.36

u/l

2.42

162

467

Osteoporosis with pathological fracture (FG)

259

911

3.01

55.08

2.7

2.1

39.99

40.86

u/l

0.24

211

785

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

1139

6996

1.67

54.97

2.1

2.0

38.88

39.83

u/l

0.83

1025

6279

Adrenocortical insufficiency

192

573

3.70

54.90

2.6

2.0

37.27

39.64

u/l

0.74

178

516

Hypopituitarism

309

1198

2.75

54.82

2.1

39.83

40.49

u/l

0.21

287

1088

Insulin, combination of fast acting with intermediate-acting or long-acting

1882

11660

1.49

54.79

2.2

2.0

41.10

39.34

u/l

2.44

1615

10340

Internal derangement of knee

1108

6685

1.68

54.54

2.0

2.1

39.47

39.81

u/l

0.22

991

5971

Other medical care

1456

7918

1.57

54.01

1.5

1.9

38.26

39.42

u/l

1.17

1286

6973

Pulmonary embolism

923

5387

1.76

53.95

2.0

1.9

38.61

39.27

u/l

0.41

814

4708

Dipeptidyl peptidase 4 (DPP-4) inhibitors

1697

8902

1.52

53.86

2.1

1.9

37.11

40.05

u/l

6.41

1421

7834

Constipation

2789

13780

1.39

53.62

1.8

2.1

39.29

39.72

u/l

0.51

2476

12293

Tumor necrosis factor alpha inhibitors

600

3081

2.03

53.60

1.7

2.1

37.57

39.93

u/l

2.33

564

2827

Other bacterial intestinal infections, including avohilmo

780

4348

1.85

53.58

1.8

1.9

38.86

39.16

u/l

0.16

668

3888

Diseases of the ear and mastoid process

3603

13579

1.35

53.53

2.0

2.1

39.54

39.72

u/l

0.20

3256

12231

COPD

1278

6552

1.62

52.94

1.8

37.72

38.89

u/l

1.16

1098

5664

Weight loss

385

1677

2.42

52.90

1.6

1.9

39.07

39.32

u/l

0.07

338

1470

Optic neuritis

213

693

3.36

52.84

1.9

2.1

38.61

40.08

u/l

0.54

208

638

Somatoform disorder

587

3005

2.03

52.81

2.1

2.0

39.91

40.19

u/l

0.13

524

2732

Other (seronegative) rheumatoid arthritis, wide

646

3419

1.96

52.67

1.7

2.0

38.18

39.70

u/l

1.19

582

3031

Diseases of arteries, arterioles and capillaries

1991

10105

1.47

52.50

1.9

2.0

38.53

39.49

u/l

1.10

1700

8869

Pulmonary heart disease

923

5430

1.75

52.43

2.0

1.9

38.61

39.27

u/l

0.41

814

4744

Mycoses

940

5566

1.74

52.31

2.2

2.0

39.94

39.36

u/l

0.34

841

4960

Oxycodone

1196

6387

1.63

52.22

1.7

2.0

38.97

39.54

u/l

0.39

1050

5620

Exposure to unspecified factor

3211

16346

1.35

52.15

1.9

2.0

39.92

39.68

u/l

0.25

2830

14741

Candidiasis, including avohilmo

1014

6130

1.70

52.08

2.1

2.0

39.90

39.47

u/l

0.26

904

5527

Non-follicular lymphoma

354

1500

2.49

51.91

2.0

1.8

42.54

38.58

u/l

2.51

315

1296

Systemic lupus erythematosus

181

539

3.70

51.88

1.7

2.1

40.07

40.04

u/l

0.01

165

488

Localized swelling, mass and lump of skin and subcutaneous tissue

1027

6233

1.69

51.87

2.2

2.0

40.34

39.37

u/l

0.79

924

5534

Other skin changes

661

3542

1.93

51.73

2.5

1.9

40.25

39.21

u/l

0.60

592

3107

Ulcer of lower limb, not elsewhere classified

487

2351

2.15

51.53

2.2

1.8

42.58

38.57

u/l

2.93

401

2036

Secondary uncertain malignant neoplasm

450

2108

2.22

51.47

1.8

41.28

38.67

u/l

1.62

401

1809

Disorders of skin appendages

1615

10817

1.51

51.45

2.0

2.1

40.85

39.61

u/l

1.63

1476

9806

Use of hypnotics and sedatives

3348

14400

1.34

50.91

2.0

2.1

39.28

39.74

u/l

0.61

2968

12964

Other anxiety disorders

1527

8624

1.53

50.90

1.9

2.1

39.23

40.06

u/l

0.93

1384

7922

Hypokalaemia

422

1938

2.27

50.79

2.0

1.9

39.41

40.05

u/l

0.25

364

1726

Other bacterial intestinal infections

603

3157

1.97

50.62

1.7

1.9

38.74

39.35

u/l

0.30

512

2801

Carpal tunnel syndrome

1909

11516

1.46

50.09

2.0

2.1

40.43

39.82

u/l

0.64

1709

10281

Polyarthritis, unspecified

172

507

3.70

49.87

1.9

2.1

38.00

38.67

u/l

0.17

149

448

Conjunctivitis (acute, non atopic)

930

5537

1.72

49.73

2.1

2.0

39.78

40.04

u/l

0.15

857

4997

Disorders of ocular muscles, binocular movement, accommodation and refraction

1544

10295

1.51

49.42

2.1

39.29

39.87

u/l

0.53

1413

9324

Cystitis

2561

11062

1.39

49.37

2.0

39.00

39.58

u/l

0.73

2300

9906

Urinary track infection

1831

6244

1.49

48.85

2.1

39.72

40.21

u/l

0.47

1669

5718

Coronary atherosclerosis

1840

7984

1.48

48.78

1.9

2.0

38.57

40.24

u/l

2.47

1531

7164

Symptoms and signs involving speech and voice

1070

6666

1.65

48.78

2.0

38.63

39.55

u/l

0.77

951

5917

Other noninfective gastroenteritis and colitis

794

4573

1.78

48.64

2.0

39.72

39.53

u/l

0.09

694

4102

Wegener granulomatosis

104

218

5.60

48.63

1.7

2.4

31.44

40.26

u/l

5.12

198

DVT of lower extremities and pulmonary embolism

1252

8054

1.58

48.53

2.0

1.9

38.35

39.24

u/l

0.75

1100

7042

Other and unspecified visual disturbances

402

1849

2.28

48.51

1.8

1.9

39.53

39.39

u/l

0.04

349

1651

Other (not insulin) diabetes medications

3058

13451

1.35

48.12

2.2

2.0

38.58

39.95

u/l

2.92

2659

12158

Cerebral cysts

244

900

2.89

47.87

1.8

2.0

40.29

39.73

u/l

0.16

219

822

Special screening examination for infectious and parasitic diseases

710

2848

1.86

47.73

2.1

41.14

39.75

u/l

1.08

649

2629

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

2992

14172

1.35

47.72

2.1

2.0

39.84

39.64

u/l

0.20

2651

12712

Benzodiazepine use

3147

16068

1.34

47.51

1.9

2.1

39.62

39.68

u/l

0.05

2779

14466

Pain in thoracic spine

523

2669

2.03

47.39

1.8

2.1

40.58

39.54

u/l

0.60

479

2406

Cholelithiasis, broad definition with cholecystitis

2668

13122

1.37

47.15

2.0

39.27

39.52

u/l

0.25

2366

11724

Diaphragmatic hernia

1120

7118

1.61

46.92

2.0

1.9

39.65

39.51

u/l

0.07

967

6263

Hypothyroidism, strict autoimmune, 3 medication purchases required

2547

12577

1.38

46.70

2.1

2.0

40.20

39.47

u/l

0.98

2309

11245

Other gastritis (incl. Duodenitis)

698

3925

1.83

46.65

2.1

1.9

41.40

39.38

u/l

1.48

623

3434

Other viral diseases

925

5599

1.69

46.54

1.9

2.0

39.39

39.86

u/l

0.28

864

5122

Other inflammation of eyelid, including avohilmo

1422

9528

1.52

46.51

2.2

2.0

39.78

39.87

u/l

0.06

1297

8633

Temporomandibular joint disorders, including avohilmo

1460

9550

1.51

45.77

1.9

2.1

39.43

39.89

u/l

0.41

1354

8725

Bacterial intestinal infections, IBD co-morbidities

596

3214

1.91

45.76

1.7

1.9

38.72

39.64

u/l

0.51

503

2845

Zoster [herpes zoster], including avohilmo

1590

10535

1.48

45.75

2.2

1.9

39.07

39.56

u/l

0.43

1432

9291

Meniscus derangement

1554

6969

1.50

45.46

2.0

2.1

40.03

39.90

u/l

0.09

1400

6202

Non-Hodgkin lymphoma, all

176

556

3.39

45.43

1.5

1.9

39.68

38.31

u/l

0.33

159

462

Anxiety (asthma-related co-morbidities)

1952

10524

1.43

45.31

2.0

2.2

39.60

40.03

u/l

0.43

1777

9641

Chronic apical periodontitis

3465

14931

1.32

45.28

2.0

39.69

39.68

u/l

0.00

3090

13457

Insulin, intermediate and long-acting

1637

10925

1.47

45.23

2.1

1.9

41.69

39.30

u/l

3.64

1395

9688

Suggestive for eosinophilic asthma

335

1475

2.39

44.97

2.0

1.9

37.22

39.31

u/l

1.06

307

1300

Venous thromboembolism

1607

10683

1.47

44.88

2.0

1.9

38.35

39.46

u/l

1.24

1423

9353

Other reaction to severe stress, and adjustment disorders

1173

7613

1.57

44.49

2.1

39.08

40.10

u/l

0.96

1063

6987

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

507

2620

2.01

44.46

1.8

2.0

42.07

39.14

u/l

2.16

457

2270

Mycoses, including avohilmo

2876

16568

1.34

44.24

2.1

2.0

39.28

39.81

u/l

0.68

2570

14907

SLE, ICD10

174

563

3.40

43.81

1.7

2.1

40.34

40.25

u/l

0.02

158

506

SLE, strict definition

174

563

3.40

43.81

1.7

2.1

40.34

40.25

u/l

0.02

158

506

Cholelithiasis

2544

12901

1.36

43.64

2.0

39.16

39.51

u/l

0.37

2258

11527

Convulsions, not elsewhere classified

613

3330

1.86

43.58

1.7

1.8

40.43

39.53

u/l

0.46

553

2980

Acetic acid derivatives and related substances

760

2219

1.80

43.38

1.8

2.0

38.07

38.44

u/l

0.19

669

1932

Other symptoms and signs involving the circulatory and respiratory systems

235

891

2.77

43.34

2.0

1.9

39.31

40.04

u/l

0.19

210

798

Fungal Sepsis

187

632

3.19

43.28

2.1

2.0

41.07

39.83

u/l

0.27

170

563

Migraine without aura and triptan purchases

569

3079

1.91

43.26

2.5

2.1

39.31

40.11

u/l

0.51

539

2879

All anxiety disorders

1987

11072

1.41

43.12

2.0

2.1

39.67

40.11

u/l

0.45

1809

10108

Selective serotonin reuptake inhibitors

2990

11760

1.34

43.08

1.9

2.1

39.67

39.68

u/l

0.01

2685

10549

Insulin, fast-acting

1092

7043

1.58

42.73

2.3

1.9

42.83

39.34

u/l

4.80

949

6293

Inflammatory diseases of the central nervous system

324

1440

2.37

42.70

2.0

36.97

39.76

u/l

1.63

294

1293

Encephalitis

156

480

3.59

42.66

1.9

2.1

34.00

39.14

u/l

2.22

143

432

Other enthesopathies

927

5760

1.65

42.60

2.1

39.83

39.84

u/l

0.00

828

5180

Enthesopathies of lower limb, excluding foot

740

4353

1.75

42.24

2.2

2.1

40.25

39.75

u/l

0.29

673

3915

Disorders resulting from impaired renal tubular function

174

575

3.31

42.17

2.0

2.1

39.55

39.48

u/l

0.02

156

519

Degeneration of macula and posterior pole

1347

6976

1.52

42.06

2.0

1.8

40.01

38.63

u/l

1.58

1165

6013

Implicit fungal Sepsis

177

590

3.24

42.04

2.1

2.0

41.02

39.68

u/l

0.29

160

524

Other/unspecified reactive arthropathies

270

1119

2.57

41.90

1.9

2.0

36.99

39.46

u/l

1.37

254

1013

Obesity, other/unspecified

1094

7099

1.58

41.86

2.2

2.1

38.85

39.77

u/l

0.77

971

6480

Adalimumab

379

1811

2.19

41.60

1.7

2.1

36.97

40.15

u/l

2.50

356

1667

Hypertensive Renal Disease

144

424

3.63

41.54

1.5

1.9

37.64

40.49

u/l

0.95

124

366

Other disorders of kidney and ureter

441

2235

2.05

41.11

2.3

1.9

38.93

39.18

u/l

0.08

389

1957

Soft tissue disorders related to use, overuse and pressure

843

5167

1.67

41.05

2.1

2.0

39.75

39.51

u/l

0.12

742

4602

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

1018

6553

1.59

40.57

2.4

2.1

38.91

40.27

u/l

1.18

892

5913

Glucagon-like peptide-1 (GLP-1) analogues

1018

6553

1.59

40.57

2.4

2.1

38.91

40.27

u/l

1.18

892

5913

Oxicams

644

2022

1.85

40.49

1.9

2.0

39.96

38.30

u/l

1.15

567

1747

Other chronic obstructive pulmonary disease

1170

6312

1.54

40.19

1.8

37.38

38.91

u/l

1.70

999

5448

Other viral diseases, not elsewhere classified, including avohilmo

846

5188

1.66

40.07

1.9

2.1

40.15

40.02

u/l

0.06

796

4736

Chronic diseases of tonsils and adenoids

2321

10848

1.37

39.99

2.2

2.1

39.73

40.15

u/l

0.44

2119

9797

Coxarthrosis [arthrosis of hip](FG)

1450

6835

1.48

39.89

1.9

2.1

39.05

40.30

u/l

1.43

1286

6006

Any mental disorder

3312

12856

1.30

39.80

1.9

2.1

39.65

39.67

u/l

0.01

2967

11572

Drug-induced adrenocortical insufficiency

113

296

4.35

39.68

3.3

2.3

35.08

39.77

u/l

1.59

107

268

Disorders of muscles

352

1664

2.20

39.52

2.2

2.0

38.54

39.51

u/l

0.40

320

1506

Drug-induced cataract

131

381

3.85

39.36

4.0

2.2

38.10

40.26

u/l

0.53

120

339

Other abnormal immunological findings in serum

113

297

4.25

39.20

1.8

2.3

38.52

39.34

u/l

0.18

105

272

Pruritus

395

1957

2.10

39.15

1.9

40.38

40.01

u/l

0.14

367

1764

Thyroiditis, ILD-related definition

388

1913

2.11

39.00

2.2

2.1

40.85

40.10

u/l

0.29

361

1742

Amiodarone users

339

1593

2.23

38.90

3.5

1.8

36.50

39.06

u/l

1.41

279

1362

469

2470

1.96

38.86

2.3

2.0

38.68

39.81

u/l

0.57

417

2258

Other encephalitis

144

448

3.54

38.72

1.9

2.1

33.22

38.73

u/l

3.05

133

405

ILD medications: pirfenidone

113

6.86

38.38

1.3

1.5

34.61

40.34

u/l

0.98

Radiculopathy

489

2620

1.92

38.35

1.9

39.55

38.85

u/l

0.32

450

2298

Biguanides

2919

13567

1.31

38.30

2.1

2.0

38.34

40.17

u/l

4.60

2528

12250

Enterocolitis due to Clostridium difficile

344

1632

2.19

38.24

1.7

1.9

37.63

38.86

u/l

0.50

285

1424

Primary biliary cholangitis, wide definition

108

279

4.25

38.14

2.1

2.3

48.68

40.28

u/l

2.75

100

254

Fall on same level

3496

14654

1.28

37.95

2.0

2.1

40.22

39.64

u/l

0.87

3111

13288

Pneumocystosis

106

274

4.38

37.83

2.2

2.1

42.67

38.26

u/l

0.96

244

Pneumocystosis, including avohilmo

106

274

4.38

37.83

2.2

2.1

42.67

38.26

u/l

0.96

244

Insulin, fast-acting or short human

1092

7254

1.53

37.36

2.3

1.9

42.83

39.22

u/l

5.10

949

6467

Protozoal diseases

144

458

3.45

37.34

2.4

2.2

41.46

38.81

u/l

0.64

131

412

Disorders of vitreous body and globe

1557

10458

1.43

37.32

2.1

2.0

40.04

39.68

u/l

0.27

1390

9209

Voice disturbances

846

5321

1.63

37.32

2.0

39.02

39.65

u/l

0.41

761

4737

Other and unspecified urticaria

629

3667

1.76

37.29

2.2

2.0

41.95

39.70

u/l

2.03

565

3332

Missing teeth due to accident, extraction or parodontitis

1866

12183

1.39

37.28

1.9

2.0

40.32

39.47

u/l

0.89

1617

10771

Cervicobrachial syndrome

691

4133

1.71

37.14

2.1

39.88

39.72

u/l

0.07

630

3715

Other diseases of hard tissues of teeth

1611

5853

1.45

37.13

1.9

2.0

39.68

39.17

u/l

0.42

1439

5150

Polyarteritis nodosa and related conditions

180

5.27

37.09

1.3

2.3

36.51

39.53

u/l

0.55

159

Other symptoms and signs involving the digestive system and abdomen

526

2918

1.85

36.90

2.1

2.0

39.95

39.91

u/l

0.01

457

2600

Other CVD

572

3252

1.81

36.87

1.9

1.7

38.18

38.95

u/l

0.38

477

2795

Hyperkalaemia

205

789

2.73

36.87

1.9

38.52

39.69

u/l

0.28

178

672

Benign intracranial hypertension

143

5.96

36.86

1.7

1.9

38.93

39.45

u/l

0.07

132

Other and unspecified nerve root and plexus disorders, also in other diseases

669

3979

1.73

36.85

2.0

39.89

40.10

u/l

0.10

595

3563

Cholecystectomy

2107

13359

1.36

36.37

2.0

39.54

39.64

u/l

0.08

1882

11902

Deforming dorsopathies

820

5142

1.63

36.33

2.1

2.0

39.54

39.67

u/l

0.06

737

4604

Angina pectoris

1522

7106

1.44

36.25

2.0

1.9

39.15

40.00

u/l

0.75

1291

6356

Diseases of the myoneural junction and muscle

401

2055

2.03

36.22

1.7

1.9

39.61

39.39

u/l

0.07

354

1813

Other disorders of ear

2757

13741

1.31

36.13

2.0

39.99

39.76

u/l

0.24

2465

12281

Paracetamol or NSAID medication

426

1060

2.06

36.04

2.0

37.97

38.71

u/l

0.28

388

939

Idiopathic gout

310

1450

2.23

35.96

1.9

1.7

36.61

38.28

u/l

0.69

264

1242

Allergic rhinitis

951

6114

1.57

35.77

2.0

2.1

39.07

40.25

u/l

1.16

867

5625

Coxarthrosis

1339

5944

1.47

35.75

1.9

2.1

39.11

39.76

u/l

0.53

1195

5225

Migraine, single triptan purchase ok & required. ICD-code if available is included

2342

12003

1.34

35.66

2.2

2.1

39.87

40.13

u/l

0.26

2179

10893

Triptan medication for migraine, single purchase ok

2342

12003

1.34

35.66

2.2

2.1

39.87

40.13

u/l

0.26

2179

10893

Other and unspecified immunodeficiencies with predominantly antibody defects

159

5.52

35.54

3.0

1.2

40.64

37.57

u/l

0.56

143

Retinal detachments and breaks

1020

6763

1.54

35.38

2.0

1.9

40.04

39.00

u/l

0.87

900

5900

Autoimmune hepatitis, wide definition

173

625

2.94

35.34

2.0

44.80

39.84

u/l

1.95

162

547

Pneumonia due to other infectious organisms, not elsewhere classified

143

466

3.31

35.33

2.0

40.84

39.37

u/l

0.31

133

415

Visual impairment including blindness (binocular or monocular)

234

979

2.50

35.29

2.1

1.9

39.75

39.10

u/l

0.17

199

855

Emphysema

239

1009

2.48

35.29

1.6

1.9

39.17

38.54

u/l

0.15

212

856

Diffuse large B-cell lymphoma, including Hilmo

186

700

2.83

35.26

2.0

1.9

42.17

39.20

u/l

0.86

164

599

Diffuse large B-cell lymphoma, helper endpoint

186

700

2.83

35.26

2.0

1.9

42.17

39.20

u/l

0.86

164

599

Diffuse large B-cell lymphoma

186

700

2.83

35.26

2.0

1.9

42.17

39.20

u/l

0.86

164

599

Other diseases of intestine

488

2689

1.87

35.13

2.0

1.9

38.23

38.95

u/l

0.35

427

2366

Disorders of vitreous body

1509

10274

1.42

34.70

2.1

2.0

40.13

39.70

u/l

0.34

1350

9055

Cerebrovascular diseases

2130

11076

1.35

34.68

1.7

2.0

38.17

39.82

u/l

2.95

1809

9777

Major coronary heart disease event excluding revascularizations

1619

7660

1.41

34.65

1.9

37.70

39.96

u/l

3.89

1334

6836

Atypical facial pain

202

801

2.68

34.47

2.0

2.1

39.73

39.88

u/l

0.04

185

718

Other disorders of conjunctiva

454

2464

1.91

34.46

2.3

1.9

38.72

39.20

u/l

0.22

404

2161

Protozoal diseases, including avohilmo

145

486

3.26

34.40

2.4

2.1

41.46

38.80

u/l

0.66

132

433

Dialysis

163

582

3.01

34.29

1.6

2.1

40.35

39.68

u/l

0.15

156

522

Other complications of surgical and medical care, not elsewhere classified

332

1625

2.13

34.16

2.1

1.9

38.42

39.79

u/l

0.64

305

1466

Asthma and opportunity respiratory infection

177

661

2.86

34.12

2.1

1.9

35.83

40.00

u/l

2.24

153

571

Neovascular glaucoma

165

594

2.97

34.09

3.0

2.0

40.70

39.04

u/l

0.41

150

531

Seropositive rheumatoid arthritis, wide

789

4991

1.62

34.00

1.6

2.0

38.11

39.60

u/l

1.24

691

4403

Injuries to the knee and lower leg

3582

15480

1.26

33.98

2.0

39.90

39.66

u/l

0.28

3212

13919

Vasculitis limited to skin, not elsewhere classified

125

386

3.54

33.98

1.6

2.1

38.02

39.44

u/l

0.32

101

345

Bell's palsy

389

2017

2.00

33.97

2.7

2.0

40.22

39.92

u/l

0.10

360

1798

Pain and other conditions associated with female genital organs and menstrual cycle

637

3167

1.72

33.94

2.1

2.0

40.14

39.93

u/l

0.10

587

2909

Childhood asthma (age<16), excluding more controls

307

1113

2.20

33.93

2.0

1.2

41.78

39.72

u/l

0.97

284

1056

Hypotension

491

2737

1.84

33.90

1.9

1.7

38.78

38.75

u/l

0.01

404

2330

Glaucoma secondary to other eye disorders

165

596

2.96

33.87

3.0

1.9

40.70

38.89

u/l

0.46

150

530

Exclusions for E4_PCOS_CONSORTIUM

2154

10110

1.35

33.80

1.9

2.1

40.00

40.12

u/l

0.09

1933

9227

Other specified/unspecified necrotizing vasculopathies

191

4.91

33.66

2.1

2.2

36.66

38.94

u/l

0.41

170

Granulomatous disorders of skin and subcutaneous tissue

131

419

3.42

33.65

2.0

2.1

41.00

38.70

u/l

0.56

122

374

Inflammatory bowel disease

967

6413

1.54

33.59

1.8

2.1

38.57

39.85

u/l

1.24

857

5810

Non-selective monoamine reuptake inhibitors

1086

7063

1.50

33.57

1.9

2.1

39.27

40.04

u/l

0.63

966

6267

Myositis

122

374

3.56

33.51

1.6

2.0

37.80

37.95

u/l

0.03

111

333

Excessive, frequent and irregular menstruation

1081

3827

1.53

33.49

2.0

39.73

40.07

u/l

0.23

987

3482

Asthma mixed form (mode), excluding more controls

144

482

3.11

33.37

2.1

1.2

39.75

39.13

u/l

0.12

132

431

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

314

1520

2.15

33.36

2.2

1.9

38.42

39.65

u/l

0.48

275

1376

Disorders of orbit

178

675

2.82

33.34

2.0

2.1

39.72

40.28

u/l

0.14

160

608

Abnormal involuntary movements

434

2347

1.91

33.32

1.6

2.0

39.32

39.63

u/l

0.11

392

2084

Other symptoms and signs involving cognitive functions and awareness

1341

8380

1.44

33.20

1.8

1.9

38.17

39.29

u/l

1.16

1158

7358

Chronic ulcer of skin, not elsewhere classified

237

1027

2.42

33.14

1.9

39.40

39.18

u/l

0.05

204

888

Endometriosis

964

3652

1.56

33.03

1.9

2.0

39.93

40.15

u/l

0.11

869

3318

Hypermobility syndrome

206

841

2.59

33.02

2.2

2.1

40.63

40.11

u/l

0.14

193

791

Primary biliary cholangitis (PBC)

262

4.09

33.01

2.3

2.2

45.43

40.45

u/l

1.31

238

Psoriatic and enteropathic arthropathies

365

1869

2.02

32.99

1.6

2.1

39.31

40.43

u/l

0.49

338

1669

Hypo-osmolality and hyponatraemia

495

2766

1.82

32.97

1.6

1.9

40.08

39.92

u/l

0.05

417

2422

Glaucoma

1595

9842

1.40

32.91

2.1

1.9

40.30

39.27

u/l

1.19

1414

8578

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1659

11649

1.38

32.86

2.1

39.57

40.15

u/l

0.61

1515

10563

Disorders of vestibular function (Vertigo)

1379

9563

1.43

32.80

1.8

2.0

38.55

39.60

u/l

1.12

1217

8436

Other and unspecified disorders of skin and subcutaneous tissue

229

986

2.45

32.62

2.3

2.0

41.88

38.89

u/l

1.35

202

874

Diseases of inner ear

1589

11091

1.39

32.53

1.8

2.0

38.68

39.62

u/l

1.04

1408

9796

Other peripheral vascular diseases

286

1350

2.21

32.51

1.8

1.9

39.47

39.85

u/l

0.11

252

1213

Malignant neoplasm, including Hilmo

2616

11823

1.30

32.27

2.1

40.88

39.78

u/l

1.73

2375

10652

Other dialysis

138

467

3.22

32.21

1.8

2.1

41.96

38.59

u/l

1.07

131

418

Volume depletion

277

1291

2.22

32.19

2.2

1.8

37.28

39.20

u/l

0.68

238

1123

Polyuria

654

4006

1.67

32.16

1.7

1.9

37.83

39.02

u/l

0.79

573

3498

Cardiodefibrillation

963

6420

1.53

32.16

2.1

1.8

37.55

38.82

u/l

1.02

794

5562

Ankylosing spondylitis

292

1395

2.18

32.07

1.9

2.1

38.14

39.36

u/l

0.52

269

1262

Thrombocytopenia, unspecified

253

1145

2.32

32.00

2.1

1.9

44.13

38.74

u/l

2.28

234

1009

Diseases of oral cavity, salivary glands and jaws

1586

5872

1.41

31.91

1.8

2.0

39.10

39.14

u/l

0.02

1401

5165

Exposure to other specified factors

2443

16280

1.30

31.89

2.0

2.1

40.24

39.69

u/l

0.65

2204

14668

Diabetic nephropathy, excluding more controls

500

2310

1.82

31.89

2.0

2.1

41.53

37.83

u/l

2.79

418

1966

Other metabolic disorders

432

2365

1.89

31.88

2.0

2.1

38.95

40.40

u/l

0.75

389

2169

Presence of other devices

654

3943

1.67

31.85

1.8

40.50

38.97

u/l

1.03

581

3403

Respiratory disorders in diseases classified elsewhere

213

4.57

31.83

1.8

2.4

35.71

39.68

u/l

0.95

190

Paralytic strabismus

244

1091

2.35

31.79

1.9

37.65

39.57

u/l

0.62

218

960

Candidiasis

467

2622

1.84

31.76

2.2

2.0

41.07

39.66

u/l

0.71

417

2365

Other and unspecified effects of external causes

837

5448

1.57

31.74

2.0

39.55

39.98

u/l

0.26

775

4960

Disease of hard tissues of teeth, NOS

1544

5794

1.41

31.72

1.9

2.0

39.47

39.22

u/l

0.19

1401

5101

Unspecified haematuria

1181

6674

1.46

31.52

1.7

1.9

37.71

39.11

u/l

1.52

1027

5842

Strabismus

786

5040

1.59

31.50

2.0

38.87

39.85

u/l

0.67

717

4551

conjunctival haemorrhage

265

1231

2.26

31.45

2.1

1.9

38.23

39.45

u/l

0.48

233

1071

Malignant neoplasm, wide definition

2614

11848

1.30

31.42

2.1

40.84

39.80

u/l

1.60

2373

10671

Childhood asthma (age<16)

307

1149

2.13

31.36

2.0

1.2

41.78

39.48

u/l

1.15

284

1083

Dentofacial anomalies [including malocclusion]

2158

12906

1.32

31.33

1.9

2.1

39.94

40.06

u/l

0.10

1994

11716

Other and unspecified vasculitis limited to skin

113

345

3.59

31.33

1.7

2.0

38.68

39.72

u/l

0.21

308

Other diseases of anus and rectum

860

5623

1.55

31.26

1.9

2.0

39.35

39.05

u/l

0.16

761

4956

Other and unspecified rosacea

324

1628

2.08

31.20

2.0

40.49

39.77

u/l

0.26

295

1472

Other external causes of accidental injury

2371

9105

1.32

31.13

2.0

2.1

39.49

u/l

0.00

2125

8262

Adverse effects, not elsewhere classified

612

3720

1.69

31.11

1.9

2.0

38.55

39.69

u/l

0.81

571

3387

Statin medication

1999

8452

1.35

31.07

2.1

2.2

38.92

40.92

u/l

3.87

1777

7858

Systemic lupus erythematosus, unspecified

141

494

3.11

31.01

1.6

2.1

41.20

40.11

u/l

0.22

128

445

Psychiatric diseases

2892

11399

1.28

31.01

1.9

2.1

39.53

39.57

u/l

0.03

2579

10268

Other disorders of eyelid

1218

8081

1.44

30.92

1.9

39.56

39.47

u/l

0.05

1075

7038

GI-bleeding

876

5786

1.54

30.91

1.8

1.9

39.69

38.95

u/l

0.45

753

5040

Nonorganic sleeping disorders, excluding more controls

623

3806

1.67

30.90

2.1

38.98

39.88

u/l

0.61

578

3485

Degenerative macular diseases

347

1789

2.00

30.78

1.8

39.71

38.21

u/l

0.69

305

1530

Inflammatory diseases of female pelvic organs

1849

9461

1.35

30.76

2.0

2.1

40.21

40.10

u/l

0.08

1676

8619

Rash and other nonspecific skin eruption

310

1539

2.09

30.73

2.1

1.9

40.91

39.39

u/l

0.58

284

1377

Fitting and adjustment of other devices

979

5811

1.51

30.71

2.0

1.8

39.57

39.24

u/l

0.18

868

5061

Noninfectious colitis NAS

432

2393

1.86

30.70

1.9

2.0

39.27

39.70

u/l

0.14

381

2164

Diseases of pulp and periapical tissues, including avohilmo

3058

12556

1.27

30.63

1.9

2.0

39.73

39.53

u/l

0.20

2726

11293

Gastric ulcer

484

2769

1.79

30.62

1.7

1.8

40.64

39.07

u/l

0.68

417

2381

Zoster [herpes zoster]

560

3343

1.72

30.53

2.3

1.9

38.06

39.31

u/l

0.76

494

2932

Polycystic ovarian syndrome, consortium definition

2096

9127

1.33

30.44

2.0

2.1

40.59

40.07

u/l

0.58

1885

8341

Asthma mixed form (mode)

144

508

2.95

30.44

2.1

1.2

39.75

38.98

u/l

0.16

132

452

Injuries to the head

3338

15939

1.25

30.38

2.0

40.45

39.54

u/l

1.59

2965

14366

Artrosis, including avohilmo

2424

10264

1.31

30.33

2.0

2.1

39.39

39.61

u/l

0.21

2180

9236

Diseases of spleen

275

3.93

30.33

2.2

2.1

42.68

38.86

u/l

0.59

252

Methotrexate

376

1999

1.93

30.28

1.7

1.5

39.83

40.11

u/l

0.09

331

1767

Other extrapyramidal and movement disorders in other diseases

748

4807

1.59

30.19

1.8

2.0

39.19

39.44

u/l

0.13

666

4238

Other/unspecified seropositive rheumatoid arthritis

765

4944

1.58

30.09

1.6

2.0

38.00

39.58

u/l

1.33

672

4363

Allergic conjunctivitis

1727

12430

1.35

30.05

2.1

39.66

40.13

u/l

0.46

1578

11289

Ulcerative colitis, NAS

445

2506

1.83

29.97

1.9

2.0

38.62

40.01

u/l

0.78

379

2280

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

756

4878

1.59

29.97

1.5

2.0

38.02

39.58

u/l

1.30

666

4309

Pleural plaque

260

1218

2.21

29.96

1.6

1.7

35.98

38.27

u/l

0.93

229

1008

Other viral diseases, not elsewhere classified

551

3284

1.71

29.78

2.0

40.18

39.70

u/l

0.20

516

2978

Accidents

2358

9105

1.31

29.76

2.0

2.1

39.52

39.49

u/l

0.02

2110

8262

Pollen allergy

565

3351

1.70

29.75

1.8

2.0

38.93

39.97

u/l

0.69

517

3117

Other diseases of lip and oral mucosa

1267

9073

1.42

29.42

2.0

40.68

39.82

u/l

0.75

1134

8109

Raynaud syndrome

315

1601

2.05

29.41

1.6

2.0

38.64

39.75

u/l

0.44

285

1460

External causes of morbidity and mortality

1913

7188

1.35

29.39

2.0

39.12

39.51

u/l

0.36

1725

6520

Microscopic polyangiitis

7.11

29.29

1.2

2.3

35.14

38.81

u/l

0.56

Ovarian cyst

971

3726

1.52

29.01

2.0

38.87

40.08

u/l

1.03

889

3387

Drug-induced osteoporosis with pathological fracture

246

4.06

28.96

3.4

2.2

38.29

40.33

u/l

0.34

219

Other specified and unspecified retinal disorders

147

545

2.89

28.90

2.0

40.34

38.68

u/l

0.44

132

487

Postprocedural endocrine and metabolic disorders, not elsewhere classified

395

2170

1.88

28.89

2.0

2.1

38.15

40.37

u/l

1.38

357

1993

Hypertrophic cardiomyopathy

165

650

2.71

28.75

3.1

2.0

37.71

39.15

u/l

0.32

135

572

Hypoparathyroidism

144

530

2.91

28.70

2.4

2.0

38.88

40.33

u/l

0.30

122

466

Other keratitis

363

1948

1.93

28.63

1.7

2.0

40.08

39.56

u/l

0.19

325

1757

Hernia

2746

14502

1.27

28.56

2.1

40.33

39.86

u/l

0.54

2420

13066

Gingivitis and periodontal diseases

2911

11978

1.27

28.37

1.9

2.1

39.71

39.65

u/l

0.05

2596

10728

Collagenous colitis

310

1589

2.03

28.22

2.2

1.9

39.59

39.38

u/l

0.06

265

1432

Other diseases of the digestive system

866

5820

1.51

28.19

1.8

1.9

39.77

38.94

u/l

0.53

744

5076

Other and unspecified drugs and medicaments

292

1467

2.07

28.17

2.2

1.9

38.50

39.41

u/l

0.31

255

1317

Falls/tendency to fall

3159

12727

1.25

28.15

2.0

2.1

40.25

39.66

u/l

0.82

2829

11542

Herpesviral [herpes simplex] infections

381

2089

1.89

28.13

2.2

2.0

39.79

39.92

u/l

0.04

341

1891

Trochanteric bursitis

442

2531

1.80

28.08

1.9

2.0

40.19

40.10

u/l

0.03

388

2264

Other and unspecified types of non-Hodgkin lymphoma, hilmo

153

587

2.77

28.05

1.7

1.9

40.54

38.87

u/l

0.41

131

513

Endocarditis

126

436

3.06

27.94

2.1

1.6

39.88

39.89

u/l

0.00

113

392

Gastroduodenal ulcer

672

4270

1.60

27.91

1.8

1.9

40.36

38.95

u/l

0.77

583

3694

Benign neoplasm: Colon, unspecified

718

4655

1.58

27.90

1.9

39.67

39.00

u/l

0.38

623

4052

Chronic hepatitis, not elsewhere classified

147

556

2.84

27.88

1.8

2.2

47.90

39.32

u/l

3.58

133

499

Diabetic retinopathy, excluding more controls

837

3077

1.56

27.87

2.1

2.2

40.76

38.44

u/l

1.94

715

2651

Menorrhagia

938

3511

1.52

27.86

2.0

40.52

40.15

u/l

0.22

844

3187

Ulcerative colitis

733

4778

1.57

27.75

1.8

2.0

38.56

39.74

u/l

0.88

644

4327

Hypogonadotropic hypogonadism

143

538

2.87

27.49

2.1

2.2

38.51

39.77

u/l

0.31

136

495

Spirochaetal infections, other/unspecified

302

1553

2.03

27.31

1.9

41.23

39.12

u/l

1.04

259

1395

Iron deficiency anaemia secondary to blood loss (chronic)

458

2671

1.76

27.24

1.8

1.9

38.46

39.37

u/l

0.38

397

2351

Malignant neoplasm

2514

11624

1.28

27.18

2.0

2.1

40.66

39.82

u/l

1.13

2282

10467

Other disorders of bone

597

3733

1.64

27.16

2.0

39.86

39.74

u/l

0.05

544

3389

Fenamates

396

1475

1.87

27.12

2.0

2.1

39.93

38.45

u/l

0.67

355

1288

Ethmoidectomy

418

2386

1.81

27.03

2.4

2.0

40.45

39.76

u/l

0.28

390

2151

Disorders of optic nerve, not elsewhere classified

306

3.56

27.03

2.2

41.25

39.90

u/l

0.19

268

Hyperhidrosis

119

407

3.09

26.93

2.0

1.9

41.41

41.32

u/l

0.02

106

369

Malignant neoplasm

2513

11633

1.28

26.93

2.0

2.1

40.63

39.83

u/l

1.05

2280

10474

Brachial plexus disorders

314

1647

1.98

26.69

1.9

2.1

40.33

39.88

u/l

0.14

295

1514

Streptococcal septicaemia

270

1342

2.08

26.69

2.0

1.9

39.25

39.58

u/l

0.09

236

1182

Other specified/unspecified inflammatory spondylopathies

176

738

2.51

26.68

1.9

2.3

39.55

39.53

u/l

0.01

160

675

Caries of dentine, including avohilmo

2209

8767

1.30

26.57

2.0

39.67

39.36

u/l

0.28

1962

7820

Other and unspecified tonsillitis

950

5438

1.47

26.56

2.1

39.38

40.10

u/l

0.54

892

5032

Rosacea

417

2391

1.80

26.53

2.1

2.0

40.14

39.75

u/l

0.15

382

2168

Macular cyst

127

457

2.99

26.50

2.6

1.9

39.01

39.40

u/l

0.08

115

402

Other disorders of patella

490

2932

1.71

26.47

2.1

39.52

39.81

u/l

0.12

444

2668

Multiple myeloma, including Hilmo

152

598

2.68

26.39

1.3

1.9

34.76

38.72

u/l

1.34

138

508

FESS (DNB20)

404

2302

1.81

26.31

2.5

2.0

40.73

39.81

u/l

0.41

376

2078

Mixed connective tissue disease

257

3.78

26.28

1.7

2.4

41.46

41.03

u/l

0.06

234

Viral hepatitis, IBD co-morbidity

134

492

2.81

26.26

1.7

2.4

47.62

40.76

u/l

1.81

121

467

Idiopathic hypercalciuria

108

6.20

26.26

3.2

2.4

44.17

40.81

u/l

0.42

Streptococcal septicaemia, including avohilmo

274

1378

2.06

26.21

2.0

1.9

39.37

39.65

u/l

0.08

240

1214

Unspecified acute lower respiratory infection

467

2774

1.73

26.04

2.1

2.0

37.77

39.60

u/l

1.20

423

2477

Anaemia in chronic diseases classified elsewhere

103

333

3.35

25.98

1.5

2.0

41.34

39.32

u/l

0.38

300

Other diseases of stomach and duodenum

214

987

2.26

25.90

2.1

1.8

38.72

39.44

u/l

0.20

193

862

Dental operations

1677

6471

1.35

25.88

1.8

2.0

39.14

39.41

u/l

0.20

1486

5673

Corneal ulcer

542

3351

1.66

25.83

2.3

2.0

41.11

39.65

u/l

0.84

493

3013

Elevated blood glucose level

270

1362

2.06

25.73

2.1

2.0

39.19

39.36

u/l

0.04

229

1222

Other inflammatory liver diseases

227

1076

2.21

25.71

2.0

1.9

43.87

39.32

u/l

2.32

207

967

Cutaneous abscess, furuncle and carbuncle

774

5190

1.52

25.66

2.1

2.0

40.14

39.47

u/l

0.37

688

4682

Kidney transplant status

191

847

2.38

25.62

1.5

2.1

38.26

39.24

u/l

0.27

183

759

Haemorrhoids and perianal venous thrombosis

940

6493

1.46

25.61

1.8

2.0

40.11

39.16

u/l

0.71

829

5720

All influenza (not pneumonia)

417

2410

1.77

25.60

2.2

2.0

39.72

40.12

u/l

0.14

377

2167

Right bundle-branch block

127

463

2.89

25.58

3.4

1.6

38.14

39.81

u/l

0.36

106

407

Dental caries, including avohilmo

2034

8044

1.31

25.47

1.9

2.0

39.88

39.15

u/l

0.85

1805

7153

Diabetic nephropathy

504

3041

1.69

25.40

2.0

2.1

41.52

37.96

u/l

2.72

422

2579

Cellulitis

651

4230

1.57

25.08

2.3

2.0

40.61

39.36

u/l

0.75

566

3772

Papulosquamous disorders

1150

8332

1.40

25.02

2.0

39.54

39.65

u/l

0.06

1023

7444

Irregular menses

1412

7881

1.36

25.00

2.0

2.1

39.85

39.95

u/l

0.07

1303

7271

Deviated nasal septum

901

6246

1.46

24.97

2.0

2.1

39.80

39.67

u/l

0.07

820

5547

Myocardial infarction

1238

6287

1.39

24.91

1.8

1.9

37.28

39.76

u/l

3.67

1008

5611

Chronic tubulo-interstitial nephritis

136

522

2.76

24.88

2.8

2.0

38.41

40.45

u/l

0.57

128

473

Calculus of kidney and ureter

828

5663

1.49

24.88

2.2

1.9

38.16

39.12

u/l

0.70

749

4976

Myelodysplastic syndrome, including Hilmo

105

352

3.17

24.70

1.6

2.0

33.43

39.65

u/l

2.25

293

Any event in cancer register

2681

12597

1.25

24.63

2.0

2.1

40.43

39.73

u/l

0.93

2441

11366

Trigeminal neuralgia

204

943

2.26

24.62

1.9

39.28

39.95

u/l

0.20

183

834

Propionic acid derivatives

708

2297

1.57

24.56

2.0

40.38

38.49

u/l

1.50

633

2007

Explicit bacterial Sepsis

308

1647

1.93

24.55

2.0

1.9

38.77

39.31

u/l

0.17

272

1452

Calcific aortic valvular stenosis, operated

723

4634

1.53

24.54

1.8

1.7

38.22

38.43

u/l

0.09

606

3923

Calcific aortic valvular stenosis

723

4634

1.53

24.54

1.8

1.7

38.22

38.43

u/l

0.09

606

3923

Operations 2 for CAVS

722

4627

1.53

24.52

1.8

1.7

38.21

38.39

u/l

0.07

605

3916

Calcific aortic valvular stenosis, diagnosis (helper)

722

4627

1.53

24.52

1.8

1.7

38.21

38.39

u/l

0.07

605

3916

Amyloidosis

303

3.39

24.50

1.4

2.1

38.53

39.50

u/l

0.15

269

Benign neoplasm of other and ill-defined parts of digestive system

524

3264

1.65

24.37

1.9

39.47

39.53

u/l

0.02

459

2865

Tuberculosis, IBD comorbidity

199

913

2.26

24.28

1.8

39.21

38.66

u/l

0.16

177

788

Hodgkin lymphoma, hilmo

120

441

2.93

24.14

1.9

2.1

43.90

38.40

u/l

1.54

111

390

Metatarsalgia

304

1631

1.92

24.10

2.2

2.1

39.67

39.72

u/l

0.01

272

1487

Nasal polyp

539

3386

1.63

24.09

2.1

1.9

39.48

39.60

u/l

0.05

491

2994

Extrapyramidal and movement disorders

1070

7708

1.41

24.09

1.7

1.9

38.87

39.47

u/l

0.47

943

6768

Monoarthritis, not elsewhere classified

146

589

2.61

24.08

1.7

2.1

38.73

38.46

u/l

0.06

136

525

Calcific aortic valvular stenosis, including rheumatic fever

723

4648

1.52

24.07

1.8

1.7

38.22

38.44

u/l

0.09

606

3935

Other sleep disorders

337

1867

1.86

24.04

2.4

1.9

40.23

40.25

u/l

0.00

310

1670

Restless leg syndrome

449

2703

1.71

23.97

1.8

2.0

39.57

39.86

u/l

0.13

396

2417

Benign neoplasm of other and unspecified endocrine glands

413

2435

1.75

23.88

2.0

1.9

38.76

39.64

u/l

0.38

369

2182

Neuralgia and neuritis, unspecified

181

807

2.35

23.87

1.9

2.0

37.47

39.61

u/l

0.69

158

727

Nephrotic syndrome

123

460

2.86

23.87

1.5

2.1

41.21

39.63

u/l

0.31

408

Unknown and unspecified causes of morbidity

193

880

2.27

23.86

2.1

1.8

37.94

39.71

u/l

0.63

180

788

Explicit bacterial Sepsis, including avohilmo

312

1693

1.90

23.77

2.0

1.9

38.88

39.34

u/l

0.14

276

1493

Lichen simplex chronicus and prurigo

213

1016

2.19

23.75

1.9

2.0

39.41

39.42

u/l

0.00

184

910

Injuries to the thorax

1286

9550

1.36

23.72

2.1

2.0

40.52

39.34

u/l

1.19

1145

8425

Other infectious diseases, including avohilmo

278

1457

1.97

23.71

2.4

1.9

39.22

39.16

u/l

0.01

253

1288

Conductive and sensorineural hearing loss

2228

11740

1.27

23.61

1.9

2.0

39.69

39.53

u/l

0.13

1991

10382

Other enthesopathy of foot (+metatarsalgia)

324

1786

1.87

23.56

2.2

2.1

39.58

39.98

u/l

0.14

290

1631

Triptan medication for migraine, min. 3 purchases

1676

9621

1.32

23.55

2.2

2.1

39.48

40.12

u/l

0.74

1581

8827

Agranulocytosis

342

1920

1.84

23.50

1.8

1.9

41.26

39.20

u/l

0.86

312

1706

Motor neuron disease ALS

230

3.70

23.49

1.7

2.0

38.56

38.75

u/l

0.03

194

Disorder of lipoprotein metabolism, unspecified

349

1967

1.82

23.48

1.9

1.8

38.29

39.48

u/l

0.45

279

1718

Motor neuron disease (with DMD)

235

3.65

23.44

1.7

1.9

38.70

38.55

u/l

0.02

199

Tuberculosis, wide, including avohilmo

206

972

2.19

23.44

1.8

38.92

38.52

u/l

0.11

183

835

IgA nephropathy (IgA glomerulonephritis)

109

389

3.04

23.29

1.6

2.2

37.37

39.01

u/l

0.32

351

COPD, hospital admissions

1171

7227

1.38

23.16

1.8

1.9

37.24

38.87

u/l

1.91

999

6259

Tuberculosis, wide

203

959

2.19

23.03

1.8

39.22

38.43

u/l

0.24

180

824

Chronic nephritic syndrome

146

604

2.57

23.02

1.6

2.0

40.39

39.17

u/l

0.24

133

534

Other abnormal uterine and vaginal bleeding

628

2931

1.57

22.97

2.0

2.1

41.52

40.42

u/l

0.71

548

2641

Anti-inflammatory and antirheumatic products, non-steroids

699

2297

1.55

22.95

1.9

2.0

39.60

38.49

u/l

0.71

627

2007

Diseases of pulp and periapical tissues and dental caries

1798

7109

1.31

22.92

1.8

2.0

39.44

39.15

u/l

0.22

1604

6297

Other shoulder lesions

292

1573

1.91

22.86

1.9

2.1

40.10

39.61

u/l

0.15

263

1438

Injury, poisoning and certain other consequences of external causes

1526

5763

1.34

22.86

2.0

2.1

39.13

39.48

u/l

0.28

1380

5223

Fissure and fistula of anal and rectal regions

677

4529

1.52

22.75

2.0

39.23

39.29

u/l

0.03

617

4048

COPD, early/later onset

1180

7288

1.38

22.69

1.8

1.9

37.32

38.86

u/l

1.77

1007

6314

Intracranial injury

1645

11847

1.31

22.68

1.9

2.0

41.26

39.29

u/l

3.02

1447

10571

Gonarthrosis,primary

2523

12289

1.25

22.58

1.9

2.0

38.89

39.84

u/l

1.46

2216

10879

Disorders of refraction and accommodation

817

5658

1.46

22.53

2.2

2.0

39.77

40.29

u/l

0.31

746

5155

Drug-induced osteoporosis

210

3.90

22.52

7.0

2.2

34.15

40.65

u/l

1.63

187

Pain associated with micturition

358

2064

1.78

22.38

1.8

2.0

37.77

39.91

u/l

1.24

313

1835

Cluster headache, wide

139

569

2.57

22.29

1.9

2.2

39.14

40.51

u/l

0.36

127

523

Other/unspecified synovitis and tenosynovitis

336

1907

1.81

22.15

2.1

38.06

39.90

u/l

0.91

302

1722

Other diseases of arteries and capillaries

270

1434

1.95

22.14

2.2

1.9

38.42

39.61

u/l

0.43

246

1265

Sensorineural hearing loss

2090

11063

1.27

22.13

2.0

39.62

39.47

u/l

0.12

1865

9739

Heartburn

335

1901

1.81

22.09

2.0

1.9

39.60

39.26

u/l

0.12

288

1689

Diabetic maculopathy, excluding more controls

310

1720

1.85

22.07

2.0

1.9

42.95

39.81

u/l

1.27

266

1564

Corticotropin deficiency

145

4.65

22.02

2.1

2.2

38.47

39.63

u/l

0.17

131

Superficial injury of lower leg

756

5208

1.48

21.93

1.9

2.0

40.03

39.89

u/l

0.06

678

4683

Psoriatic arthropathies

298

1638

1.87

21.90

1.6

2.0

40.43

39.80

u/l

0.21

279

1458

Injuries to the abdomen, lower back, lumbar spine and pelvis

1121

8139

1.38

21.90

1.9

40.66

39.42

u/l

1.15

981

7227

Oter anti-inflammatory and antirheumatic agents, non-steroids

531

1818

1.63

21.86

1.9

2.0

38.90

38.17

u/l

0.32

476

1554

COPD related to multimorbidity

1009

6164

1.40

21.74

1.7

1.8

36.89

38.69

u/l

1.99

844

5320

Recurrent aphthous stomatitis , including avohilmo

429

2619

1.68

21.68

2.1

2.0

39.63

39.71

u/l

0.03

390

2358

Cardiac arrest

172

652

2.31

21.65

2.5

1.7

38.27

40.90

u/l

0.73

138

606

Generalized anxiety disorder

468

2913

1.64

21.59

1.9

2.0

37.57

39.76

u/l

1.94

434

2710

Endometriosis of pelvic peritoneum

463

2610

1.65

21.59

1.9

2.1

38.32

40.21

u/l

1.27

413

2390

Suppurative and necrotic conditions of lower respiratory tract

181

843

2.24

21.51

2.0

1.9

36.94

38.69

u/l

0.67

159

741

Lesion of ulnar nerve

414

2513

1.69

21.41

2.3

2.0

40.15

39.98

u/l

0.06

381

2254

L04AC Interleukin inhibitors

229

1168

2.04

21.36

1.5

2.1

39.46

39.96

u/l

0.14

212

1072

Thyrotoxicosis, other and/or unspecified

574

3763

1.56

21.34

2.3

2.0

39.50

39.48

u/l

0.00

508

3379

Urolithiasis

865

6140

1.43

21.32

2.2

1.9

38.01

38.98

u/l

0.75

781

5387

Sacroiliitis, not elsewhere classified

165

743

2.32

21.28

1.9

2.3

36.84

39.09

u/l

0.88

154

691

Early onset COPD

613

4081

1.53

21.24

2.0

38.20

39.48

u/l

0.85

526

3593

Sequelae of external causes of morbidity and mortality

720

4950

1.48

21.19

2.0

1.9

38.73

39.34

u/l

0.35

654

4365

Type 1 diabetes, wide definition, subgroup 1

561

3661

1.56

21.12

2.1

2.0

45.30

39.96

u/l

5.23

496

3388

Other disorders of veins

1173

8617

1.36

21.09

2.0

40.02

39.79

u/l

0.14

1013

7698

Other chronic obstructive pulmonary disease, including avohilmo

1425

8950

1.32

21.01

1.7

1.9

37.65

39.17

u/l

1.96

1224

7801

Cluster headache, strict

132

543

2.56

21.00

2.0

2.2

39.03

40.47

u/l

0.37

120

503

Complications of internal orthopaedic prosthetic devices, implants and grafts

589

3899

1.54

20.90

1.9

39.75

39.26

u/l

0.22

513

3385

Diseases of external ear

989

7207

1.39

20.86

1.9

2.0

40.17

39.44

u/l

0.53

861

6407

Psoriasis

818

5778

1.44

20.81

1.9

2.0

39.25

39.76

u/l

0.31

734

5152

Cerebral palsy and other paralytic syndromes

325

1865

1.79

20.70

1.7

1.9

37.76

39.63

u/l

0.96

289

1671

Sixth [abducent] nerve palsy

123

494

2.64

20.70

1.9

2.0

35.91

40.09

u/l

1.33

112

439

Ankylosing spondylitis, ICD10

285

1578

1.87

20.65

2.0

2.1

38.16

39.85

u/l

0.82

262

1430

Heart failure and hypertrophic cardiomyopathy

267

3.35

20.64

3.6

2.2

36.75

40.01

u/l

0.47

236

Other abnormal findings of blood chemistry

165

754

2.29

20.63

2.0

2.1

41.89

38.63

u/l

1.04

152

674

Viral pneumonia (unknown virus, not influenza)

219

1115

2.04

20.48

2.4

2.0

36.95

39.70

u/l

1.10

199

1002

Stomatitis and related lesions

579

3839

1.54

20.46

2.0

39.77

39.63

u/l

0.06

525

3460

Malignant immunoproliferative diseases

148

4.37

20.43

1.7

2.3

39.86

39.79

u/l

0.01

133

Idiopathic thrombocytopenic purpura

114

445

2.73

20.36

3.1

2.0

44.80

39.06

u/l

1.25

104

398

Sequelae with surgical and medical care as external cause

571

3780

1.54

20.35

1.9

38.41

39.52

u/l

0.67

526

3321

Valvular operations

334

1939

1.76

20.25

2.0

1.6

38.09

39.60

u/l

0.63

281

1730

Special screening examination for other diseases and disorders

298

1672

1.82

20.25

2.0

41.08

39.17

u/l

0.88

276

1487

Multiple myeloma and malignant plasma cell neoplasms

157

709

2.32

20.22

1.3

1.9

34.63

38.82

u/l

1.46

143

612

Dermatitis due to substances taken internally

178

845

2.20

20.15

2.5

2.0

38.39

39.65

u/l

0.34

161

760

Special screening examination for neoplasms

182

872

2.15

19.95

1.9

39.98

40.09

u/l

0.02

154

778

COPD-related respiratory insufficiency

314

1803

1.79

19.95

1.9

1.8

35.28

38.55

u/l

1.98

265

1539

Panic disorder

420

2604

1.65

19.90

1.9

2.0

39.33

40.05

u/l

0.32

383

2424

Injuries to the shoulder and upper arm

2453

15510

1.23

19.89

1.9

2.0

40.19

39.71

u/l

0.54

2180

13883

Retention of urine

874

5058

1.42

19.88

1.6

1.8

37.61

38.77

u/l

0.81

752

4392

Herpesviral [herpes simplex] infections, including avohilmo

744

5214

1.45

19.79

2.2

2.0

39.91

40.05

u/l

0.07

673

4747

Behavioural syndromes associated with physiological disturbances and physical factors

2723

15255

1.22

19.52

2.1

40.72

39.71

u/l

1.78

2448

13746

Glaucoma-related operations

176

844

2.18

19.46

2.2

1.8

38.46

39.57

u/l

0.31

159

731

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, including Hilmo

5.18

19.43

1.5

2.0

36.71

37.41

u/l

0.07

Covid-19 suspected case

610

4132

1.50

19.41

2.0

39.12

39.85

u/l

0.42

562

3772

Amyloidosis, other/unspecified

250

3.33

19.39

1.4

2.1

40.23

39.26

u/l

0.14

227

COPD, hospital admission 2, with asthma infections

807

4935

1.43

19.39

1.7

1.8

37.23

38.79

u/l

1.36

683

4254

Other symptoms and signs involving the urinary system

298

1701

1.80

19.39

1.8

1.9

37.55

39.46

u/l

0.79

279

1476

Isolated proteinuria

109

427

2.72

19.38

1.8

2.1

42.98

38.79

u/l

1.01

383

Dermatographic urticaria

224

1173

1.98

19.35

1.6

2.1

42.00

39.59

u/l

1.02

213

1077

Other specified/unspecified soft tissue disorders

149

670

2.31

19.29

2.2

1.9

39.99

39.00

u/l

0.25

143

601

Type 1 diabetes

654

4487

1.48

19.26

2.1

2.0

44.68

39.92

u/l

5.18

582

4116

Injuries to the ankle and foot

2099

14532

1.24

19.22

2.1

40.53

39.75

u/l

0.98

1892

13191

IBD patients in KELA-register

652

4484

1.48

19.21

1.7

2.0

38.22

39.73

u/l

1.21

578

4083

Injuries to the wrist and hand

2934

16240

1.21

19.20

2.0

40.18

39.63

u/l

0.75

2652

14582

Other infectious diseases

223

1168

1.97

19.18

2.4

1.9

37.77

39.17

u/l

0.41

203

1022

Benign thyroid growths and nodules

883

5946

1.40

19.12

1.9

2.0

40.32

39.84

u/l

0.29

790

5244

Atopic dermatitis

1671

10510

1.28

19.09

2.0

2.1

40.24

39.86

u/l

0.35

1527

9572

Glaucoma suspect

969

7139

1.38

19.07

2.3

1.9

40.61

39.49

u/l

0.96

864

6219

Abnormal findings on examination of urine, without diagnosis

147

663

2.33

19.02

1.7

2.0

40.84

39.03

u/l

0.42

122

597

Crohn disease

382

2344

1.67

19.00

1.6

2.0

37.83

39.65

u/l

1.12

346

2143

Spondylolisthesis/Spondylolysis

502

3281

1.56

19.00

2.1

2.0

40.34

39.37

u/l

0.47

455

2921

Acute generalized exanthematous pustulosis

153

702

2.29

18.99

2.7

2.0

37.49

39.28

u/l

0.53

136

629

Retinal vascular disorders

312

1814

1.76

18.96

1.9

1.8

39.45

38.09

u/l

0.58

263

1548

Thyrotoxicosis

711

4986

1.45

18.90

2.3

2.0

39.08

39.73

u/l

0.36

632

4473

Retinal vascular occlusion

309

1794

1.77

18.89

1.9

1.8

39.38

38.11

u/l

0.52

261

1532

6-mercaptopurine

109

430

2.65

18.86

1.6

40.53

41.47

u/l

0.19

392

Oesophageal varices

143

641

2.35

18.83

1.9

51.94

38.95

u/l

6.55

125

562

Neuromuscular dysfunction of bladder

267

1491

1.85

18.76

1.6

2.0

37.97

39.57

u/l

0.67

237

1323

Other/unspecified rheumatoid arthritis

334

1987

1.73

18.73

1.7

1.9

39.02

39.56

u/l

0.19

300

1744

Phlebitis and thrombophlebitis (not including DVT)

626

4297

1.48

18.66

2.0

39.45

39.47

u/l

0.01

564

3818

Crystal arthropathies, rheuma endpoint

235

3.33

18.59

1.9

2.1

35.01

40.83

u/l

1.68

205

Other abnormalities of plasma proteins

226

3.42

18.57

2.0

2.3

40.74

38.89

u/l

0.27

201

Other/unspecified enthesopathies of lower limb, excluding foot

224

1188

1.95

18.56

2.1

40.34

39.32

u/l

0.34

208

1085

Nonorganic sleeping disorders

623

4277

1.48

18.56

2.1

2.0

38.98

39.81

u/l

0.55

578

3912

Solid cancers, including Hilmo

2442

11693

1.23

18.55

2.1

40.87

39.81

u/l

1.59

2215

10528

Cardiomyopathy, Hypertrophic obstructive

220

3.41

18.55

3.5

1.7

39.62

41.28

u/l

0.20

199

Ascites

213

1111

1.98

18.53

1.7

1.8

44.72

39.06

u/l

2.21

184

971

Dislocation, sprain and strain of joints and ligaments at neck level

456

2936

1.59

18.53

1.7

2.0

39.49

39.53

u/l

0.01

411

2697

Other and unspecified disorders of vitreous body

1166

8673

1.33

18.50

2.2

2.0

39.67

39.79

u/l

0.07

1037

7633

Other and unspecified myopathies

251

1383

1.87

18.44

1.8

1.9

39.97

39.16

u/l

0.22

222

1210

Impingement syndrome of shoulder

627

4318

1.48

18.36

2.1

2.0

41.41

39.48

u/l

1.57

548

3842

Lung diseases due to external agents

354

2147

1.69

18.35

2.0

1.8

39.57

38.56

u/l

0.33

318

1850

Allergic purpura

113

463

2.59

18.28

1.9

2.3

38.76

38.80

u/l

0.01

417

Injuries to the neck

653

4537

1.46

18.26

1.9

2.0

39.70

39.67

u/l

0.01

586

4113

Sleep disorders

2622

15005

1.21

18.21

2.1

40.78

39.76

u/l

1.77

2362

13531

Mouth breathing

1080

8141

1.34

18.15

2.2

2.1

39.90

39.54

u/l

0.22

971

7266

Coeliac disease

344

2085

1.69

18.00

2.0

42.24

39.79

u/l

1.31

318

1891

Seborrhoeic dermatitis

289

1673

1.78

17.95

1.7

1.9

38.93

39.27

u/l

0.10

269

1487

Type 1 diabetes, wide definition

572

3882

1.50

17.91

2.2

2.0

45.09

39.85

u/l

5.20

505

3582

Other and unspecified coagulation defects

173

852

2.12

17.91

1.9

2.1

39.33

39.39

u/l

0.01

153

773

Granuloma annulare

226

3.37

17.91

1.8

1.9

38.59

40.18

u/l

0.26

203

Postmenopausal osteoporosis with pathological fracture

186

939

2.06

17.88

2.4

1.9

41.92

40.01

u/l

0.50

148

823

Bipolar affective disorders

519

3462

1.53

17.86

1.8

2.1

39.38

39.77

u/l

0.18

466

3196

Vitreous haemorrhage

296

1729

1.76

17.85

1.9

43.40

39.34

u/l

1.93

273

1516

Personality disorders, excluding more controls

688

4840

1.44

17.66

1.9

2.2

41.11

39.96

u/l

0.72

617

4476

Diabetic retinopathy

997

4594

1.37

17.64

2.0

2.1

40.85

38.26

u/l

2.66

838

3928

Selective deficiency of immunoglobulin G [IgG] subclasses

4.98

17.60

2.6

1.2

39.38

38.65

u/l

0.08

Inflammatory bowel disease, strict (require KELA)

652

4561

1.45

17.60

1.7

2.0

38.22

39.80

u/l

1.30

578

4155

Pleural plaque with presence of asbestos

190

972

2.02

17.55

1.6

35.73

36.98

u/l

0.34

164

807

Familial hypercholesterolemia

357

2195

1.66

17.55

1.6

1.7

37.28

39.26

u/l

1.00

289

1901

Hyperkinetic disorders, excluding more controls

332

1863

1.69

17.53

1.7

2.1

39.21

39.78

u/l

0.22

303

1782

Persons with potential health hazards related to communicable diseases

1025

7647

1.34

17.49

2.0

38.22

40.19

u/l

2.51

942

7063

Cardiac murmurs and other cardiac sounds

226

1211

1.89

17.31

2.3

1.8

38.47

40.32

u/l

0.72

202

1109

Benign paroxysmal vertigo

796

5783

1.40

17.27

1.7

2.0

38.11

39.74

u/l

1.36

689

5087

Misadventures to patients during surgical and medical care

401

2550

1.61

17.25

2.1

1.9

39.38

39.71

u/l

0.12

357

2267

Other crystal arthropathies

246

3.17

17.24

1.9

2.1

35.01

38.34

u/l

0.75

213

Viral and other specified intestinal infections, including avohilmo

738

5085

1.41

17.23

2.0

39.96

39.66

u/l

0.14

678

4696

Guillain-Barre syndrome

242

3.23

17.22

1.9

2.3

33.42

39.33

u/l

1.58

218

Other follicular disorders

240

1335

1.86

17.19

2.0

38.98

39.47

u/l

0.14

224

1220

Failure and rejection of transplanted organs and tissues

191

3.55

17.14

2.3

2.6

39.16

39.09

u/l

0.01

173

Allergic urticaria

248

1395

1.83

17.08

2.2

2.0

40.45

39.76

u/l

0.21

224

1278

Mucosal proctocolitis

370

2315

1.64

17.07

1.8

2.0

38.76

39.76

u/l

0.45

325

2121

Unspecified/other endometriosis

266

1493

1.79

17.03

2.0

2.1

39.72

39.84

u/l

0.03

245

1408

Other coagulation defects

228

1252

1.88

17.03

2.0

39.96

39.50

u/l

0.12

198

1142

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

122

534

2.40

17.00

3.0

2.1

39.52

39.78

u/l

0.05

114

471

Other strabismus

584

4017

1.47

16.89

2.0

39.40

40.13

u/l

0.39

534

3656

Otalgia

250

1414

1.82

16.89

2.2

2.0

41.39

40.35

u/l

0.39

222

1294

Hallux valgus (acquired)

809

4191

1.40

16.88

2.1

40.19

40.16

u/l

0.02

724

3728

Flat foot [pes planus] (acquired)

269

1554

1.78

16.84

2.0

2.1

41.86

40.12

u/l

0.78

239

1388

Spontaneous rupture of synovium and tendon

233

1291

1.86

16.83

1.6

1.9

40.93

39.57

u/l

0.42

204

1146

Etanercept

210

1130

1.93

16.78

1.4

2.1

38.09

39.99

u/l

0.81

193

1037

Benign neoplasm: Transverse colon

310

1866

1.71

16.77

2.4

1.8

38.68

39.01

u/l

0.10

269

1623

Haemorrhage, not elsewhere classified

109

455

2.49

16.77

1.4

1.8

37.80

38.66

u/l

0.17

394

Chronic lymphocytic leukaemia, helper endpoint

391

2.64

16.74

1.6

1.9

41.40

38.57

u/l

0.57

329

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

391

2.64

16.74

1.6

1.9

41.40

38.57

u/l

0.57

329

Chronic lymphocytic leukaemia

391

2.64

16.74

1.6

1.9

41.40

38.57

u/l

0.57

329

Cervicocranial syndrome

303

1812

1.71

16.70

2.1

2.0

41.25

38.78

u/l

1.31

274

1627

Nonalcoholic steatohepatitis

151

3.95

16.70

2.0

2.5

56.52

40.57

u/l

2.83

138

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

345

2.75

16.66

1.2

1.9

33.77

38.88

u/l

1.52

294

Multiple myeloma

345

2.75

16.66

1.2

1.9

33.77

38.88

u/l

1.52

294

Other disorders of nervous system

204

1090

1.94

16.66

2.2

1.9

40.14

39.00

u/l

0.34

179

969

Systemic atrophies primarily affecting the central nervous system

137

635

2.26

16.65

1.7

2.0

38.11

38.89

u/l

0.20

124

554

Marginal zone B-cell lymphoma, including Hilmo

221

3.28

16.53

2.4

2.2

47.77

39.80

u/l

1.91

189

Achilles tendinitis

298

1782

1.72

16.47

2.1

38.82

39.56

u/l

0.27

269

1602

1018

6937

1.34

16.45

2.0

1.8

40.15

38.56

u/l

1.58

882

5952

Speech disturbances, not elsewhere classified

248

1411

1.81

16.41

1.8

36.75

39.27

u/l

0.98

212

1231

Other and unspecified disorders of white blood cells

136

633

2.25

16.40

2.6

2.0

40.78

39.17

u/l

0.30

120

560

Benign neoplasm: Ascending colon

387

2473

1.60

16.38

1.9

1.8

38.11

39.12

u/l

0.43

331

2146

Acute pharyngitis

403

2567

1.58

16.36

1.9

2.1

38.12

40.53

u/l

1.76

370

2360

Seropositive rheumatoid arthritis, strict definition

420

2738

1.57

16.26

1.4

2.0

38.04

39.79

u/l

0.99

370

2431

Use of pramipexole

590

4119

1.46

16.19

2.0

1.9

39.39

39.75

u/l

0.17

510

3628

Third [oculomotor] nerve palsy

267

3.03

16.17

1.8

2.2

33.94

39.53

u/l

1.73

236

Ischaemic Stroke, excluding all haemorrhages

1437

8368

1.28

16.15

1.7

1.9

37.30

39.40

u/l

3.27

1202

7300

Alcoholic liver disease

280

1660

1.73

16.04

1.5

1.9

48.08

38.58

u/l

6.96

254

1457

Mature T/NK-cell lymphomas, hilmo

195

3.42

15.93

1.4

2.3

44.82

40.00

u/l

0.80

172

Ganglion

558

3864

1.47

15.92

2.2

2.1

42.23

39.79

u/l

2.21

510

3507

Other peripheral vertigo

260

1516

1.77

15.85

1.9

39.47

39.49

u/l

0.01

228

1346

Psoriasis vulgaris

516

3529

1.49

15.82

1.9

2.0

38.86

39.67

u/l

0.42

464

3166

Trigger finger

396

2562

1.58

15.81

1.9

2.1

41.75

39.98

u/l

0.96

352

2310

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

724

5187

1.40

15.75

1.7

2.1

41.17

39.90

u/l

0.82

653

4777

Other juvenile arthritis

115

506

2.36

15.74

2.1

40.44

40.24

u/l

0.03

105

480

Alzheimer disease, including avohilmo

454

4668

0.67

15.71

1.6

1.7

37.51

38.52

u/l

0.42

367

3944

Insomnia

2556

14953

1.20

15.71

2.0

2.1

40.74

39.81

u/l

1.52

2300

13503

Atopic dermatitis, strict definition with reimbursement

802

5683

1.37

15.68

1.9

2.0

39.98

39.87

u/l

0.06

734

5250

Other hammer toe(s) (acquired)

408

2412

1.57

15.65

2.0

42.55

39.61

u/l

1.96

348

2095

Paralytic ileus and intestinal obstruction

638

4536

1.42

15.62

1.7

1.9

38.63

39.06

u/l

0.21

558

3964

Macular pucker

412

2701

1.56

15.55

2.2

1.8

41.82

38.52

u/l

2.70

366

2318

Transport accidents

1289

8434

1.28

15.54

2.0

2.1

40.66

39.59

u/l

1.07

1176

7652

Fibroblastic disorders

575

4022

1.45

15.53

1.9

41.58

39.00

u/l

2.16

506

3532

Stroke, excluding SAH

1532

8856

1.26

15.47

1.7

2.0

37.67

39.53

u/l

2.70

1283

7747

Solid cancers

2340

11436

1.21

15.45

2.1

40.75

39.78

u/l

1.36

2125

10285

Artificial joint operation, meniscal resection

2518

13532

1.20

15.44

2.0

39.38

39.79

u/l

0.44

2233

12017

Respiratory tuberculosis, confirmed, including avohilmo

224

3.13

15.39

1.7

2.1

42.23

38.36

u/l

0.79

193

Excessive attrition of teeth

1731

13977

1.24

15.38

2.0

2.1

39.90

39.75

u/l

0.11

1581

12632

Actinic keratosis

922

6332

1.34

15.34

2.0

1.8

40.11

38.45

u/l

1.56

795

5402

Faecal incontinence

249

1447

1.77

15.32

1.9

38.23

39.54

u/l

0.46

221

1276

Respiratory tuberculosis, bacteriologically and histologically confirmed

230

3.09

15.31

1.7

2.1

42.23

38.81

u/l

0.66

200

Respiratory tuberculosis, confirmed

220

3.14

15.23

1.7

2.1

42.23

38.63

u/l

0.71

190

Gout due to impairment of renal function

160

3.66

15.23

2.8

2.1

41.22

40.08

u/l

0.17

144

Pyothorax

137

658

2.17

15.23

2.0

1.9

36.38

38.72

u/l

0.85

119

578

Post-traumatic stress disorder

234

1337

1.79

15.23

2.1

37.96

39.95

u/l

1.12

215

1262

Transient ischemic attack

1327

8357

1.28

15.22

1.8

1.9

38.22

39.47

u/l

1.45

1151

7284

Adhesive capsulitis of shoulder

433

2881

1.53

15.19

1.9

2.0

42.35

39.71

u/l

1.85

396

2568

Visual field defects

232

1327

1.80

15.14

1.7

1.9

37.25

39.24

u/l

0.81

205

1165

Diseases of male genital organs

1301

5122

1.29

15.14

1.9

2.1

39.28

39.73

u/l

0.30

1162

4567

Peripheral artery disease

1032

6246

1.32

15.12

1.8

38.68

39.03

u/l

0.18

853

5390

Hernia of abdominal wall

1218

9580

1.29

15.12

2.0

39.59

39.28

u/l

0.21

1077

8478

Atherosclerosis, excluding cerebral and coronary sclerosis

961

5727

1.33

15.11

1.8

38.40

39.05

u/l

0.37

790

4921

Osteomyelitis

188

1012

1.92

15.03

2.7

1.8

41.18

38.74

u/l

0.65

165

887

Vitamin deficiency

146

721

2.10

15.01

1.5

1.9

39.09

38.87

u/l

0.05

136

645

Vitamin deficiency, wide

146

721

2.10

15.01

1.5

1.9

39.09

38.87

u/l

0.05

136

645

Stroke, including SAH

1625

9437

1.25

14.96

1.7

2.0

37.78

39.63

u/l

2.81

1358

8280

Pyogenic arthritis

176

927

1.95

14.95

2.1

1.9

37.39

38.65

u/l

0.34

148

814

Acute pancreatitis

511

3526

1.47

14.94

1.8

2.0

39.75

39.42

u/l

0.13

451

3103

Alzheimer disease

370

4047

0.65

14.90

1.5

1.7

38.74

38.45

u/l

0.08

290

3400

Skin changes due to chronic exposure to nonionizing radiation

948

6533

1.33

14.88

2.0

1.8

39.95

38.50

u/l

1.31

819

5589

Other diseases of oesophagus

245

1429

1.76

14.86

2.1

1.9

39.27

39.33

u/l

0.01

219

1246

Dissociative [conversion] disorders

119

546

2.27

14.80

1.6

2.2

39.40

39.68

u/l

0.05

109

511

Unstable angina pectoris

842

4940

1.35

14.77

1.8

37.65

39.47

u/l

1.65

704

4363

Other bursopathies

344

2191

1.60

14.76

2.4

2.0

39.19

39.35

u/l

0.05

310

1950

Other/unspecified enthesopathies, not elsewhere classified

228

1307

1.79

14.74

2.1

2.0

39.86

39.31

u/l

0.14

200

1175

Juvenile arthritis (FINNGEN)

127

599

2.19

14.69

2.0

2.2

40.20

41.10

u/l

0.19

116

564

Generalized skin eruption due to drugs and medicaments

130

622

2.19

14.64

2.9

2.1

38.07

39.34

u/l

0.30

115

554

Autonomic disorders

369

2.58

14.64

1.7

2.2

36.06

39.15

u/l

0.71

330

Ptosis of eyelid

295

1818

1.66

14.57

2.3

1.9

39.19

39.42

u/l

0.07

264

1586

Lesion of lateral popliteal nerve

150

757

2.06

14.57

2.4

2.1

40.84

39.04

u/l

0.42

138

673

Thyroiditis

216

1227

1.82

14.53

2.3

2.0

38.00

40.36

u/l

0.99

198

1118

Epilepsy

734

5393

1.37

14.51

1.9

40.07

39.86

u/l

0.09

660

4811

Use of antiglaucoma preparations and miotics

200

1108

1.85

14.51

1.8

39.24

38.94

u/l

0.07

177

955

Gluteal tendinitis

137

670

2.13

14.50

2.5

2.2

39.09

39.04

u/l

0.01

125

606

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

506

3506

1.47

14.50

2.2

2.0

40.14

39.72

u/l

0.19

465

3241

Diseases of middle ear and mastoid

1570

10393

1.24

14.50

2.0

2.1

39.90

39.64

u/l

0.20

1422

9444

Hepatic failure, not elsewhere classified

122

572

2.23

14.48

2.4

2.1

47.85

39.78

u/l

2.21

110

508

Hypocalcemia

384

2.55

14.48

1.9

2.2

40.47

39.61

u/l

0.13

342

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

448

3036

1.50

14.44

1.8

2.0

39.11

39.88

u/l

0.36

394

2769

Hyperplasia of prostate

891

3763

1.35

14.43

1.9

2.0

36.76

38.78

u/l

2.02

784

3278

Periodontitis

2822

15353

1.18

14.36

1.9

2.1

40.37

39.67

u/l

0.94

2496

13788

Abnormal blood-pressure reading, without diagnosis

129

618

2.16

14.34

1.7

1.9

40.71

40.10

u/l

0.12

115

560

Exophthalmic conditions

141

3.72

14.34

2.1

2.6

40.51

39.75

u/l

0.08

129

Allergic contact dermatitis

369

2405

1.57

14.33

1.9

2.0

38.75

39.93

u/l

0.57

337

2191

Cholangitis (primary sclerosing, PSC)

175

935

1.93

14.31

1.7

1.9

41.09

38.94

u/l

0.63

157

828

Unspecific neurodegenerative disorder

567

5443

0.71

14.29

1.5

1.7

37.73

38.32

u/l

0.25

470

4612

Cluster headache, wide,, including avohilmo

173

924

1.94

14.26

1.9

2.2

38.44

39.88

u/l

0.46

160

841

Procreative management

928

5828

1.33

14.26

2.0

2.2

40.71

40.52

u/l

0.11

857

5355

Cholecystitis

356

2304

1.57

14.22

2.0

1.8

39.30

38.85

u/l

0.14

303

2011

Dislocation, sprain and strain of joints and ligaments of knee

1733

12877

1.23

14.19

2.0

2.1

40.18

39.88

u/l

0.25

1575

11676

Barrett oesophagus

153

786

2.02

14.16

1.9

2.0

37.55

39.31

u/l

0.50

139

683

Chronic periodontitis, including avohilmo

2814

15353

1.18

14.04

1.9

2.1

40.39

39.68

u/l

0.95

2487

13793

Caries of enamel

2751

15371

1.18

14.00

2.2

2.0

40.33

39.80

u/l

0.71

2485

13858

Heterophoria

226

1314

1.77

13.96

2.2

2.0

38.86

40.05

u/l

0.43

211

1203

Other disorders of cornea

267

1624

1.69

13.93

2.1

1.9

40.07

39.24

u/l

0.28

243

1455

Dental pulpitis, including avohilmo

2633

14358

1.18

13.88

2.0

2.1

40.13

39.78

u/l

0.38

2400

13011

Cluster headache, strict, including avohilmo

166

885

1.95

13.79

1.9

2.2

38.31

39.97

u/l

0.53

153

806

Umbilical hernia

731

5437

1.36

13.79

2.1

2.0

39.14

39.26

u/l

0.06

648

4866

Acute myeloid leukaemia and myelodysplastic syndromes

278

2.76

13.74

1.6

2.0

34.56

39.53

u/l

1.18

231

Diseases of appendix

2069

15503

1.20

13.74

2.1

39.96

39.77

u/l

0.16

1871

13971

Chondropathies

414

2791

1.51

13.74

2.0

39.71

u/l

0.00

375

2530

Need for other prophylactic measures

177

964

1.90

13.73

2.9

2.0

35.58

39.95

u/l

2.92

163

861

Myocardial infarction, without ST-elevation

947

6578

1.31

13.72

1.8

37.46

38.68

u/l

0.94

785

5651

Nontoxic multinodular goitre

485

3371

1.46

13.71

1.9

41.76

39.54

u/l

1.42

430

2948

Tuberculosis of other organs

257

2.84

13.63

1.7

2.1

38.48

38.43

u/l

0.01

226

Car occupant injured in other and unspecified transport accidents

503

3526

1.45

13.57

2.2

1.9

40.99

39.60

u/l

0.82

461

3218

Appendicitis, broad definition

2053

15447

1.20

13.57

2.1

39.97

39.78

u/l

0.16

1856

13919

Fracture of rib(s), sternum and thoracic spine

790

5964

1.34

13.44

1.9

39.77

39.34

u/l

0.21

694

5242

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

716

5264

1.36

13.42

1.9

2.0

39.37

39.57

u/l

0.10

641

4887

COPD, hospital admissions 3, with asthma pneumonia sepsis

631

3931

1.39

13.41

1.6

1.8

36.69

38.44

u/l

1.38

528

3369

Astigmatism

179

983

1.87

13.39

1.7

2.0

39.27

40.39

u/l

0.32

164

893

Primary gonarthrosis, bilateral

1340

9030

1.25

13.35

1.8

2.0

39.05

39.66

u/l

0.50

1161

7911

Tubulo-interstitial nephritis, not specified as acute or chronic

173

941

1.89

13.35

1.9

36.85

40.03

u/l

1.22

153

847

Ulcerative colitis (strict definition, require KELA)

455

3143

1.47

13.33

1.8

2.0

39.06

39.87

u/l

0.39

401

2860

Myocardial infarction, strict

1062

5869

1.29

13.33

1.9

37.34

39.75

u/l

3.08

871

5230

Other disorders of bladder

305

1938

1.61

13.30

1.8

37.69

39.05

u/l

0.64

276

1692

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

270

1670

1.66

13.23

1.9

38.84

39.31

u/l

0.14

237

1474

Phobic anxiety disorders

348

2272

1.55

13.23

1.8

2.0

38.74

40.17

u/l

0.71

329

2117

Other specified/unspecified bacterial intestinal infections

188

1055

1.84

13.20

1.8

1.9

40.94

39.01

u/l

0.63

160

940

Persistent mood disorders

503

3544

1.44

13.20

1.9

2.1

38.92

39.83

u/l

0.48

441

3189

Nummular dermatitis

227

1345

1.73

13.13

2.0

1.9

40.02

39.36

u/l

0.21

206

1183

Other local infections of skin and subcutaneous tissue

286

1797

1.63

13.12

1.9

2.0

39.02

39.39

u/l

0.11

254

1612

Striking against or struck by other objects

897

6904

1.31

13.11

2.0

40.36

39.81

u/l

0.35

786

6272

Tuberculosis of other organs, strict, including avohilmo

297

2.65

13.10

1.6

2.0

37.98

39.25

u/l

0.21

261

Benign neoplasm: Stomach

263

1622

1.66

13.07

1.9

38.22

39.48

u/l

0.46

223

1436

Diabetic neuropathy

326

2106

1.58

13.07

2.0

2.1

42.51

37.49

u/l

3.20

273

1786

Algoneurodystrophy

112

530

2.21

13.05

1.7

2.2

39.75

39.50

u/l

0.04

105

489

Excessive vomiting in pregnancy

232

1387

1.72

12.99

1.8

2.0

38.58

39.70

u/l

0.39

219

1294

Tuberculosis of other organs, strict

287

2.67

12.94

1.6

2.1

38.54

38.97

u/l

0.06

251

Degenerative diseases of the nervous system

465

4759

0.70

12.89

1.5

1.7

38.98

38.42

u/l

0.20

375

4031

Diseases of tongue

170

931

1.88

12.88

1.8

2.1

39.74

39.52

u/l

0.05

153

816

Rare circulating lymphoid malignancy, including Hilmo

348

2.49

12.80

1.6

2.0

41.30

38.14

u/l

0.56

302

N06DA Anticholinesterases

435

4815

0.69

12.76

1.5

1.7

37.23

38.54

u/l

0.57

358

4057

Use of anticholinesterases

435

4815

0.69

12.76

1.5

1.7

37.23

38.54

u/l

0.57

358

4057

Tuberculosis

148

777

1.96

12.76

1.8

39.07

38.59

u/l

0.12

133

665

KRA_PSY_EATING, excluding more controls

193

1088

1.79

12.74

1.6

2.1

39.45

39.46

u/l

0.00

174

1035

677

4312

1.36

12.73

1.8

1.7

39.19

38.52

u/l

0.34

565

3642

Appendectomy

1788

14195

1.21

12.70

2.2

2.1

40.17

39.87

u/l

0.27

1620

12860

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

480

3380

1.44

12.70

1.8

2.0

38.72

39.88

u/l

0.65

423

3074

Persons encountering health services for specific procedures, not carried out

240

1456

1.69

12.69

2.0

39.44

39.96

u/l

0.15

212

1321

Hydronephrosis

280

1764

1.62

12.66

2.0

1.8

37.73

39.35

u/l

0.70

257

1561

Other facial nerve disorders

439

2.32

12.64

1.6

2.1

39.36

40.00

u/l

0.12

389

Gonarthrosis, primary, with knee surgery

1482

9431

1.23

12.64

1.9

2.0

38.76

39.67

u/l

0.90

1290

8253

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

209

1223

1.75

12.62

1.8

2.1

39.49

39.90

u/l

0.13

191

1126

Benign neoplasm: Adrenal gland

225

1347

1.72

12.62

2.0

1.9

38.13

39.41

u/l

0.41

200

1195

Endometriosis of rectovaginal septum and vagina

200

1158

1.77

12.58

2.0

39.29

40.59

u/l

0.39

185

1049

Other blood glucose lowering drugs, excl. Insulins

378

2548

1.51

12.56

2.0

1.8

37.84

40.00

u/l

0.96

331

2225

Early lumbar disc prolapse, operated

272

1706

1.63

12.56

2.3

2.2

41.38

39.58

u/l

0.85

260

1601

Other and unspecified follicular disorders

133

681

2.03

12.50

2.4

2.0

39.66

40.01

u/l

0.07

124

616

Use of memantine

297

3676

0.64

12.49

1.4

1.6

36.83

38.49

u/l

0.69

234

3057

Use of other anti-dementia drugs

297

3676

0.64

12.49

1.4

1.6

36.83

38.49

u/l

0.69

234

3057

Viral infections of the central nervous system

210

1237

1.75

12.49

2.2

2.1

39.23

39.84

u/l

0.17

193

1119

Monoplegia

230

2.89

12.48

1.8

2.3

40.43

39.62

u/l

0.12

204

Problems related to lifestyle

285

1812

1.61

12.42

1.6

2.0

42.85

39.15

u/l

1.87

256

1649

Viral pneumonia (known virus, not influenza)

404

2.36

12.41

2.0

1.9

37.12

38.84

u/l

0.34

357

Non-allergic asthma

228

1373

1.70

12.39

1.8

1.9

41.57

39.41

u/l

0.82

193

1230

Polyarteritis nodosa

4.41

12.34

1.3

2.3

33.68

38.93

u/l

0.85

Colonic or urogenital fistula

712

5369

1.34

12.31

2.0

39.06

39.50

u/l

0.24

651

4785

Alzheimer’s disease, strict definition

268

3389

0.63

12.30

1.4

1.6

38.28

38.47

u/l

0.05

209

2818

Other meningitis

249

2.79

12.27

1.8

2.3

38.15

40.25

u/l

0.39

229

Atrophic disorders of skin

427

2965

1.47

12.24

2.5

2.0

41.25

39.88

u/l

0.73

390

2664

Mantle cell lymphoma, including Hilmo

166

3.22

12.23

1.7

2.1

39.38

38.13

u/l

0.15

141

Dermatophytosis

369

2493

1.51

12.19

2.1

1.9

39.63

39.39

u/l

0.07

327

2217

Other and unspecified glaucoma

180

1021

1.81

12.18

2.1

1.8

38.64

39.17

u/l

0.12

160

871

Acute pancreatitis (for exclusion)

511

3667

1.42

12.14

1.8

1.9

39.75

39.49

u/l

0.10

451

3226

Disorders of oesophagus in diseases classified elsewhere

297

2.60

12.14

1.9

2.0

39.28

37.70

u/l

0.23

255

Postzoster neuralgia

216

2.91

12.13

1.8

2.2

42.54

39.41

u/l

0.45

189

Other and unspecified vascular occlusions

224

1351

1.70

12.11

1.9

1.8

38.70

38.39

u/l

0.08

188

1159

Lichen simplex chronicus

109

526

2.16

12.09

2.4

2.1

40.49

39.81

u/l

0.11

477

Nontoxic goitre/thyroid nodule

741

5635

1.33

12.08

1.8

2.0

41.17

39.85

u/l

0.98

663

4969

Stenosis and insufficiency of lacrimal passages

241

1483

1.66

12.07

2.3

1.9

40.19

39.93

u/l

0.07

213

1324

Charcot foot

228

2.83

12.02

3.3

1.9

46.23

39.86

u/l

0.79

212

Moderate visual impairment, binocular

358

2.41

12.02

1.7

2.0

40.12

38.61

u/l

0.23

313

Infections with a predominantly sexual mode of transmission

814

6257

1.31

12.02

2.3

2.1

42.03

39.89

u/l

2.20

745

5783

Benign neoplasm: Cerebral meninges

256

1604

1.64

11.97

2.0

1.9

38.91

39.79

u/l

0.29

222

1439

Type of accident

763

5832

1.32

11.96

2.1

1.9

41.04

39.58

u/l

0.93

683

5224

Vascular disorders of the intestines

168

939

1.83

11.91

1.8

1.9

39.33

38.30

u/l

0.24

139

802

Acute appendicitis, no complications

1515

12456

1.22

11.90

2.2

2.1

40.37

39.79

u/l

0.52

1379

11319

Acute appendicitis

1914

14994

1.19

11.87

2.1

40.06

39.73

u/l

0.29

1735

13538

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

1044

8199

1.27

11.85

1.9

2.1

40.97

39.95

u/l

0.88

952

7538

Other noninfective disorders of lymphatic vessels and lymph nodes

119

599

2.07

11.79

2.2

2.1

38.94

39.76

u/l

0.17

108

538

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma

4.80

11.77

1.6

2.2

34.04

38.17

u/l

0.45

Vitamin B12 deficiency anaemia

247

1538

1.64

11.76

1.5

1.8

37.02

38.95

u/l

0.86

206

1335

Supplementary factors related to causes of morbidity and mortality classified elsewhere

818

6327

1.31

11.75

2.1

2.0

41.18

39.72

u/l

0.99

733

5667

Otitis externa

604

4478

1.37

11.74

1.8

2.0

40.28

39.54

u/l

0.39

533

4020

Viral infections of the central nervous system, including avohilmo

222

1350

1.69

11.73

2.2

2.0

39.32

39.76

u/l

0.13

203

1226

Benign neoplasm of meninges

276

1769

1.60

11.72

2.0

38.71

39.83

u/l

0.43

239

1582

Fracture of lumbar spine and pelvis

546

3975

1.39

11.68

1.9

42.56

39.12

u/l

2.76

460

3449

Chronic conjunctivitis

467

2.22

11.68

2.4

2.2

40.40

39.31

u/l

0.25

415

Nonsuppurative otitis media, including avohilmo

820

5475

1.31

11.64

1.9

40.29

39.70

u/l

0.35

743

5025

Simple and mucopurulent chronic bronchitis

104

499

2.15

11.59

1.9

2.1

39.48

39.29

u/l

0.03

430

Other and unspecified local infections of skin and subcutaneous tissue

266

1695

1.61

11.57

1.9

2.0

38.89

39.38

u/l

0.15

236

1525

Endometriosis ASRM stages 1,2

471

3365

1.42

11.55

1.9

2.1

38.42

40.18

u/l

1.20

421

3125

Postmenopausal bleeding

659

2557

1.37

11.54

2.1

40.07

41.10

u/l

0.61

575

2272

Pneumothorax

178

1023

1.79

11.54

2.2

2.0

41.49

39.21

u/l

0.65

154

891

Other disorders of iris and ciliary body

385

2.33

11.51

2.5

2.2

44.63

37.91

u/l

1.99

342

Infective dermatitis

292

1905

1.56

11.42

2.0

1.9

37.76

39.59

u/l

0.84

268

1693

Respiratory tuberculosis

130

680

1.97

11.40

1.9

38.97

38.67

u/l

0.06

117

591

Respiratory tuberculosis, confirmed and not-confirmed

130

680

1.97

11.40

1.9

38.97

38.67

u/l

0.06

117

591

Acute lymphadenitis

171

977

1.80

11.38

1.8

2.1

40.40

39.60

u/l

0.17

154

904

Blepharochalasis

709

5410

1.33

11.30

1.8

1.9

39.35

39.62

u/l

0.12

623

4714

Acute laryngitis and tracheitis

297

1917

1.55

11.25

2.2

2.1

41.52

40.29

u/l

0.44

276

1786

Superficial injury of abdomen, lower back and pelvis

411

2879

1.45

11.24

1.7

1.9

40.40

39.32

u/l

0.51

376

2589

Disturbance of activity and attention

326

2129

1.52

11.20

1.7

2.0

39.29

40.28

u/l

0.43

298

2029

Chondrocostal junction syndrome [Tietze]

118

604

2.03

11.16

1.9

2.1

38.03

39.46

u/l

0.32

102

545

Autoimmune hyperthyroidism

157

879

1.83

11.13

2.4

2.1

40.56

40.28

u/l

0.05

142

794

Scoliosis

207

1252

1.69

11.10

2.2

2.0

38.67

39.01

u/l

0.09

186

1140

Peripheral arterial reconstruction

374

2580

1.47

11.08

1.7

38.84

38.19

u/l

0.20

302

2203

Other diseases of blood and blood-forming organs

188

1112

1.74

11.07

1.8

1.9

41.01

38.90

u/l

0.73

161

981

Dystonia

157

883

1.84

11.06

1.6

2.1

39.85

39.48

u/l

0.08

140

800

Discitis, unspecified

221

2.78

11.05

1.5

2.2

33.56

37.36

u/l

0.77

199

Haemolytic anaemias

103

504

2.13

11.03

2.5

2.0

35.51

39.18

u/l

0.94

448

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

1755

13489

1.19

10.98

1.9

2.1

39.22

39.93

u/l

0.79

1595

12276

therapeutic use

460

2.18

10.90

2.4

2.1

41.56

39.89

u/l

0.35

404

Psoriatic arthropathies, ICD10

294

1944

1.55

10.90

1.6

2.0

40.00

39.68

u/l

0.10

276

1760

Unspecified fall

1318

10650

1.22

10.88

1.9

2.0

40.33

39.49

u/l

0.74

1151

9484

Paraplegia, diplegia of upper limbs

332

2.41

10.87

1.5

2.2

34.85

39.23

u/l

1.05

298

Recurrent dislocation and subluxation of joint

180

1056

1.75

10.86

1.7

2.1

39.40

39.71

u/l

0.09

166

974

Other diseases of pancreas

224

1393

1.65

10.85

2.1

1.9

39.38

38.79

u/l

0.17

203

1224

Nonsuppurative otitis media

562

3606

1.37

10.84

1.9

40.42

39.59

u/l

0.42

505

3322

COPD, hospital admissions 1, only main diagnosis

792

5287

1.30

10.80

1.7

1.8

36.94

38.62

u/l

1.57

672

4548

Optic atrophy

260

2.61

10.76

2.0

2.3

38.45

39.20

u/l

0.10

239

Other noninflammatory disorders of vagina

201

1218

1.69

10.74

2.1

40.68

40.49

u/l

0.04

182

1107

Retinal breaks without detachment

421

2990

1.43

10.74

2.2

1.9

39.79

39.14

u/l

0.27

384

2630

Myelodysplastic syndrome

136

3.28

10.71

1.4

2.1

33.00

38.91

u/l

0.95

112

Unspecified nephritic syndrome

316

2.43

10.65

1.7

2.3

37.83

39.53

u/l

0.27

279

Primary adrenocortical insufficiency

170

3.06

10.62

2.3

2.4

38.79

38.62

u/l

0.02

155

Amenorrhoea

172

1003

1.75

10.59

1.6

1.9

40.48

39.48

u/l

0.30

157

946

Malignant neoplasm of heart, mediastinum and pleura, including Hilmo

214

2.75

10.57

1.7

2.1

35.83

38.96

u/l

0.45

179

Substance use, excluding alcohol

523

3859

1.37

10.55

1.6

2.1

42.20

39.80

u/l

1.59

454

3526

Panniculitis affecting regions of neck and back

105

526

2.07

10.53

1.7

2.1

40.87

38.19

u/l

0.80

469

Plantar fascial fibromatosis

260

1685

1.57

10.53

2.1

42.04

39.88

u/l

0.98

236

1535

Superficial injury of wrist and hand

545

4047

1.36

10.53

2.1

2.0

40.74

39.99

u/l

0.37

494

3695

Other specified and unspecified disorders of eye and adnexa

113

582

2.02

10.52

2.5

2.2

40.59

39.57

u/l

0.23

104

515

Endometriosis of ovary

427

2868

1.42

10.49

2.1

40.65

40.30

u/l

0.12

383

2610

Background retinopathy and retinal vascular changes

306

2.44

10.46

2.9

2.2

41.15

39.49

u/l

0.28

276

Other or unspecified ileus, impaction or obstruction

431

3083

1.42

10.44

1.7

1.9

38.55

38.93

u/l

0.14

376

2688

Osteonecrosis

177

1048

1.74

10.43

1.9

1.8

40.47

39.25

u/l

0.35

156

929

Infections with a predominantly sexual mode of transmission, including avohilmo

1051

7764

1.25

10.42

2.2

2.1

41.13

39.76

u/l

1.36

964

7188

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

786

6148

1.29

10.41

2.0

2.1

39.78

40.08

u/l

0.16

723

5598

Extreme obesity with alveolar hypoventilation

126

676

1.94

10.41

2.0

36.77

40.10

u/l

0.99

109

597

Pyoderma gangrenosum

119

3.50

10.40

1.7

2.5

36.91

40.43

u/l

0.48

106

Arthropathic psoriasis

310

2094

1.51

10.38

1.6

2.0

40.78

39.82

u/l

0.36

291

1885

Convalescence

149

841

1.82

10.38

1.9

37.22

40.01

u/l

0.89

130

762

Congenital malformations, deformations and chromosomal abnormalities

1573

12537

1.20

10.34

1.9

2.1

39.23

39.82

u/l

0.55

1424

11432

Maternal care for other conditions predominantly related to pregnancy

546

3968

1.36

10.25

1.9

2.1

39.46

39.84

u/l

0.19

508

3738

Carbimazole or st.post thyroidectomy, condition for graves disease

556

4162

1.36

10.24

2.2

2.1

39.16

39.85

u/l

0.33

490

3766

Other female pelvic inflammatory diseases

413

2949

1.42

10.24

2.0

2.1

39.65

39.87

u/l

0.09

375

2666

Substance abuse, excluding more controls

1444

10062

1.21

10.24

1.7

2.1

40.45

39.33

u/l

1.10

1262

9050

Inflammatory diseases of prostate (prostatitis)

314

2131

1.50

10.22

1.9

40.97

38.71

u/l

1.06

283

1853

Alzheimer’s disease (Late onset)

247

3103

0.65

10.15

1.4

1.6

38.01

38.39

u/l

0.11

190

2567

Tinnitus

612

4651

1.33

10.14

2.2

2.0

39.46

39.73

u/l

0.13

546

4131

Myopia

342

2364

1.47

10.13

2.2

2.1

39.41

39.75

u/l

0.11

315

2192

Other chondrocalcinosis

180

2.92

10.11

1.9

2.2

35.41

40.93

u/l

1.07

159

Superficial injury of hip and thigh

366

2560

1.45

10.11

1.6

1.9

38.66

39.02

u/l

0.13

322

2255

Nail disorders

234

1498

1.60

10.07

2.5

2.0

41.28

39.78

u/l

0.47

215

1358

Acquired haemolytic anaemia

343

2.32

10.07

2.5

2.1

35.02

38.80

u/l

0.74

301

Benign neoplasm: Sigmoid colon

469

3430

1.39

10.06

2.1

1.9

39.06

39.15

u/l

0.03

404

2989

Other spirochaetal diseases, including avohilmo

915

7324

1.26

10.05

2.0

42.13

39.61

u/l

3.24

807

6547

Other disorders of the musculoskeletal system and connective tissue

379

2677

1.44

10.01

1.7

2.0

39.79

39.54

u/l

0.09

339

2371

Superficial injury of thorax

386

2734

1.43

10.00

2.2

1.9

42.03

39.53

u/l

1.38

344

2433

Diseases of peritoneum

254

1659

1.56

9.97

1.8

1.9

39.86

39.12

u/l

0.22

232

1466

Other psoriatic arthropathies

282

1886

1.53

9.95

1.6

2.0

40.26

39.63

u/l

0.21

264

1712

Optic atrophy, wide definition

270

2.51

9.94

2.0

2.3

38.45

39.14

u/l

0.10

246

Suppurative and unspecified otitis media

913

6461

1.26

9.93

2.1

2.0

40.33

39.75

u/l

0.36

842

5944

Thoracic aortic aneurysm

356

2490

1.46

9.93

1.8

37.58

38.96

u/l

0.62

307

2166

Other hearing loss

654

4866

1.32

9.90

1.9

1.8

39.91

38.97

u/l

0.56

568

4189

Aortic aneurysm

521

3801

1.36

9.90

1.7

36.85

38.50

u/l

1.05

448

3268

Sequelae of cerebrovascular disease

850

5754

1.27

9.89

1.6

1.8

37.12

39.15

u/l

1.88

708

4982

Other disorders of pigmentation

127

694

1.89

9.88

2.0

39.82

39.13

u/l

0.14

116

612

Unspecified chronic bronchitis

429

2.14

9.87

1.9

2.0

36.38

38.37

u/l

0.43

368

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

133

737

1.86

9.87

1.7

2.2

41.53

39.35

u/l

0.59

126

677

Crohn's disease NAS

182

1102

1.70

9.87

1.6

2.1

37.90

39.75

u/l

0.70

165

1012

Infection of intervertebral disc (pyogenic)

188

2.83

9.85

1.5

2.3

43.83

37.80

u/l

0.91

168

Mental and behavioural disorders due to tobacco

243

1578

1.58

9.85

1.6

2.0

42.29

39.49

u/l

1.20

200

1422

Radial styloid tenosynovitis [de Quervain]

157

914

1.76

9.83

2.0

2.1

37.83

40.10

u/l

0.84

145

850

Hyperkinetic disorders

332

2237

1.47

9.77

1.7

2.0

39.21

40.13

u/l

0.40

303

2131

Malignant neoplasm of heart, mediastinum and pleura

161

2.96

9.70

1.4

2.2

31.87

38.74

u/l

1.57

134

Cyst of kidney

188

1154

1.67

9.67

2.7

1.9

41.21

39.44

u/l

0.46

162

998

Smoking dependency

243

1585

1.57

9.66

1.6

2.0

42.29

39.39

u/l

1.27

200

1429

Necrosis of pulp, including avohilmo

1607

13470

1.19

9.64

2.0

2.1

40.07

39.82

u/l

0.18

1458

12212

Varicose veins

1544

9830

1.19

9.62

2.1

2.0

39.50

39.65

u/l

0.10

1357

8700

Unspecified urinary incontinence

224

1436

1.59

9.58

2.0

40.79

39.85

u/l

0.32

201

1270

Acute gastritis

183

1118

1.67

9.55

1.7

1.9

39.43

39.51

u/l

0.02

165

977

Other disorders of optic disc

215

2.68

9.54

2.2

2.4

38.85

39.98

u/l

0.15

196

Otitis externa, unspecified

299

2040

1.49

9.53

2.0

42.08

39.43

u/l

1.31

268

1851

Viral and other specified intestinal infections

490

3545

1.36

9.53

2.0

39.64

39.76

u/l

0.04

448

3276

Viral warts, including avohilmo

557

4215

1.34

9.52

2.4

2.0

40.64

39.94

u/l

0.32

505

3832

Enteropathic arthropathies

332

2.30

9.50

1.6

2.4

34.38

39.65

u/l

1.69

306

Primary open-angle glaucoma

716

5385

1.29

9.50

2.0

1.8

40.41

38.96

u/l

1.07

618

4598

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

545

3370

1.35

9.47

1.7

1.8

37.76

38.69

u/l

0.49

470

2880

Adult-onset Still disease

4.52

9.47

1.8

2.5

40.44

42.45

u/l

0.17

Synovial cyst of popliteal space [Baker]

183

1121

1.67

9.46

2.2

1.9

38.52

39.08

u/l

0.13

157

1002

Dermatophytosis, including avohilmo

1766

14816

1.18

9.42

2.0

39.29

39.76

u/l

0.42

1579

13306

Other spirochaetal diseases

899

7238

1.26

9.41

2.0

42.30

39.61

u/l

3.55

793

6473

DVT of lower extremities

449

3296

1.38

9.41

2.1

1.9

36.90

39.24

u/l

1.60

392

2896

Familial hypercholesterolemia, with ischemic heart disease

209

1324

1.61

9.40

1.7

1.8

37.35

38.86

u/l

0.46

166

1125

Other and unspecified diseases of blood and blood-forming organs

413

2.15

9.40

2.1

2.2

39.19

38.80

u/l

0.06

366

Other noninflammatory disorders of vulva and perineum

239

1563

1.56

9.33

2.3

2.1

38.06

40.22

u/l

0.96

212

1426

Other ulcerative colitis

167

1005

1.71

9.32

2.0

2.1

39.67

39.94

u/l

0.06

151

918

Ulcerative colitis (strict definition, all Crohn cases excluded)

371

2647

1.42

9.28

1.8

2.0

39.58

39.89

u/l

0.11

323

2412

Personal history of allergy to drugs, medicaments and biological substances

177

2.84

9.27

2.1

42.17

41.18

u/l

0.12

162

Amputation

231

1502

1.57

9.24

2.0

1.8

42.10

38.48

u/l

1.17

189

1288

Iron deficiency

476

2.04

9.21

1.7

2.2

38.01

40.59

u/l

0.57

445

Atopic dermatitis, strict definition

751

5800

1.28

9.21

1.9

2.0

40.02

39.90

u/l

0.06

687

5387

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

516

3372

1.35

9.21

1.7

2.0

39.17

39.90

u/l

0.37

476

3204

Noninflammatory disorders of female genital tract

951

3828

1.26

9.19

2.0

39.99

40.07

u/l

0.04

874

3483

Fracture of foot, except ankle

642

4986

1.30

9.09

2.0

41.17

39.94

u/l

0.77

569

4535

Complications of other internal prosthetic devices, implants and grafts

108

576

1.93

9.08

1.8

2.0

40.82

39.34

u/l

0.28

511

Wet age-related macular degeneration

363

2492

1.42

9.06

1.9

1.6

39.39

38.68

u/l

0.25

305

2078

Disorders of myoneural junction and muscle in diseases classified elsewhere

130

3.21

9.04

2.2

2.3

44.09

40.64

u/l

0.41

116

Toxic liver disease

239

2.53

9.03

1.8

2.4

46.23

39.48

u/l

0.69

222

Intestinal malabsorption

136

781

1.80

9.03

1.7

2.1

43.58

39.44

u/l

1.21

126

701

Spirochaetal infections, other/unspecified, including avohilmo

895

7241

1.25

8.99

2.0

42.30

39.57

u/l

3.62

789

6472

Other contact dermatitis

207

1324

1.60

8.97

2.0

40.96

40.07

u/l

0.25

182

1202

Acute peritonitis

161

969

1.70

8.96

1.8

1.9

40.22

38.93

u/l

0.32

147

846

Lyme disease, including avohilmo

889

7191

1.25

8.95

2.0

42.29

39.61

u/l

3.48

783

6435

Lyme disease

889

7191

1.25

8.95

2.0

42.29

39.61

u/l

3.48

783

6435

Pure hyperglyceridaemia

321

2.28

8.95

1.7

2.1

35.60

40.19

u/l

0.97

294

Late syphilis

204

2.67

8.95

3.1

2.3

39.79

39.27

u/l

0.05

182

Open wound of head

1401

11103

1.19

8.91

1.9

2.0

40.91

39.32

u/l

1.85

1225

9869

Lateral epicondylitis

336

2376

1.44

8.86

2.0

2.1

40.64

40.34

u/l

0.10

304

2166

Follicular lymphoma, hilmo

115

635

1.87

8.74

1.8

2.0

40.47

39.77

u/l

0.12

106

556

Testicular dysfunction

124

702

1.83

8.69

1.8

2.1

41.45

40.19

u/l

0.25

111

630

Injuries to the hip and thigh

1193

8916

1.21

8.68

1.7

1.9

39.17

39.35

u/l

0.11

1042

7821

Other specific arthropathies, wide

306

2.29

8.67

1.6

2.4

35.54

40.60

u/l

1.16

279

Chronic pancreatitis

306

2138

1.46

8.66

1.7

1.9

44.68

38.94

u/l

3.73

280

1877

Personality disorders

688

5426

1.28

8.64

1.9

2.1

41.11

39.85

u/l

0.83

617

5000

Status epilepticus

480

2.00

8.63

1.7

1.9

39.27

39.70

u/l

0.06

430

Ovarian dysfunction

191

1210

1.61

8.63

1.7

2.1

43.41

39.29

u/l

1.96

181

1149

Mesothelioma, including Hilmo

149

2.91

8.62

1.5

2.1

31.87

39.83

u/l

1.60

123

Intestinal stricture

741

5897

1.27

8.61

1.8

1.9

39.30

39.21

u/l

0.04

651

5156

Prurigo nodularis

373

2.16

8.61

1.9

2.3

37.14

40.70

u/l

1.03

335

Disorders of breast

1284

9493

1.20

8.59

2.1

41.14

40.13

u/l

1.06

1180

8608

Dementia in Alzheimer disease

174

2305

0.62

8.59

1.4

1.6

39.25

38.74

u/l

0.08

134

1926

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

774

6195

1.26

8.57

2.0

2.1

39.48

39.56

u/l

0.04

698

5562

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS